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ABSTRACT 
 
Influence of Dietary Composition on Coccidiosis Vaccination Efficacy in Broilers. 
(December 2006) 
Jason Thomas Lee, B.S., Texas A&M University; 
M.S. Texas A&M University 
Chair of Advisory Committee: Dr. David J. Caldwell 
 
 
This research program included a series of experiments to investigate the effect 
of starter diet protein level on the performance of broilers vaccinated with Coccivac®-B 
and subsequently challenged with a mixed species Eimeria challenge compared to non-
vaccinated broilers.  Pre-challenge performance data indicates that vaccination may 
decrease body weights and increase feed conversion ratio (FCR) with vaccination.  The 
time period associated with the observed effects is between 13 to 17 d of age.  This 
reduction in performance of vaccinated broilers versus non-vaccinated broilers was 
eliminated by the conclusion of the experiments (27 d) in the higher protein diets.  
Vaccination was effective at generating protective immunity against the Eimeria 
challenge evidenced by significantly increased body weight gains, improved feed 
conversions, reduced post-challenge mortality, and reduced lesion development in 
vaccinated broilers compared to non-vaccinated.   
The final experiment included the comparison of Coccivac®-B to Bio-Cox® 
(salinomycin) for controlling field strain Eimeria in broilers reared on two different 
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dietary rations varying in protein concentration.  Diet A had a lower protein 
concentration than Diet B.  On day 14, Eimeria collected from commercial broiler farms 
in Texas were spray applied to the litter in all pens.  Broilers reared on Diet B were 
heavier at Day 40 while body weights at day 50 were similar for all groups.  Broilers fed 
Diet B had lower FCR during the starter and finisher diets.  Broilers fed salinomycin had 
lower FCR for the starter and grower diets while vaccinated broilers had lower FCR 
during the withdrawal period.  Cumulative FCR for the entire grow out period were 
similar for all groups.   
These data indicate that vaccination can be utilized as an anticoccidial preventive 
and are suggestive that reduced protein concentration of starter diets can lead to 
significant losses in broiler performance when utilizing a vaccination program to prevent 
coccidiosis.  Feeding an appropriately formulated diet while vaccinating broilers with 
Coccivac®-B as an alternative to the use of salinomycin yields at least equivalent if not 
elevated performance in the presence of field-strain Eimeria during grow-out with no 
effect on the cost of production. 
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CHAPTER I 
INTRODUCTION 
Intestinal parasitism is a major stress factor leading to malnutrition, lowered 
performance, and reduced production efficiency of livestock and poultry (Yun et al., 
2000). Coccidiosis is an intestinal infection caused by an obligate intracellular protozoan 
parasite belonging to several different species of Eimeria.  Developmental stages of 
Eimeria alternate between the external environment and endogenously within the host 
(Lillehoj and Lillehoj, 2000).  Coccidiosis is recognized as the parasitic disease that has 
the greatest economic impact on the commercial poultry industry.  In 1995, it was 
estimated to cause a loss of approximately 40 million pounds on production in the UK of 
625 million broilers with an estimated $800 million dollars of lost revenue worldwide 
(Williams, 1999).  The U.S. broiler industry is estimated to lose between $450 million 
(Allen and Fetterer, 2002a) and $1.5 billion (Yun et al., 2000) annually from coccidial 
infections in floor reared poultry.  From this estimate, 17.5% of these costs were due to 
the cost of prophylaxis and treatment in broilers and broiler-breeders (Williams, 1998) 
and 80% were due to losses of feed conversion and weight gain even in the presence of 
drug-treatment strategies (Vermeulen et al., 2001).   
Infections with Eimeria acervulina, E. maxima, and E. tenella are diagnosed 
frequently in intensively reared poultry (McDougald et al., 1997), and commercial 
chicken flocks which are found to be free from coccidiosis are extremely rare (Williams,  
___________  
This dissertation follows the style of Poultry Science. 
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1999).  Seven Eimeria species have been recognized to infect chickens: Eimeria 
acervulina, E. maxima, E. tenella, E. brunette, E. necatrix, E. mitis, and E. praecox.  
Each species has its own characteristic prevalence, site of infection, pathogenicity, and 
immunogenicity (Rose and Long, 1980).  All species, however, parasitize the epithelial 
cells of the intestinal mucosa and cause pathological changes varying from local 
destruction of the mucosal barrier and underlying tissue (often associated with some 
degree of inflammation resulting in endothelial lesions), to systemic effects such as 
blood loss, shock syndrome, and even death (Vermeulen et al., 2001).  Coccidial 
infections may be classified in one of three ways: (1) as clinical coccidiosis, 
characterized by mortality, morbidity, diarrhea, and/or bloody feces; (2) as subclinical 
coccidiosis, by definition not immediately obvious, but causing reductions in weight 
gain and feed conversion efficiency of the host, without overt signs of disease; or (3) as 
coccidiasis, a mild infection causing no adverse effects on the host (Williams, 2002).  
To date, the poultry industry has relied heavily on the use of anticoccidial feed 
additives for prevention of coccidiosis outbreaks.  Resistance, in some capacity, to all of 
the anticoccidial drugs introduced thus far for use in commercial poultry has developed 
in field strain Eimeria (Chapman, 1997).  Consumers are becoming increasingly 
concerned about drug residues in poultry products (McEvoy, 2001), resulting in 
increased pressure from a percentage of consumers to ban drugs from animal feeds.  For 
these reasons, there is a pressing need to move away from chemotherapeutic control of 
coccidiosis in favor of non-medicated forms of control such as vaccination (Williams, 
2002).  Due to the complexity of the life cycle of Eimeria which consists of intracellular, 
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extracellular, asexual, and sexual stages or pathways, it is not surprising that host 
immunity is complex and involves many components of non-specific and specific 
immunity (Lillehoj, 1998).  Such complexities associated with the integrated host 
response to the parasite’s developmental stages must be taken into account during 
vaccine development. 
Live oocyst vaccination is currently the only viable alternative to the use of anti-
coccidial drugs.  This control strategy has been used by the poultry industry for over 50 
years, primarily in broiler breeder and replacement layer stock (Chapman et al., 2002).  
The basis for vaccination is the fact that, after an infection, the host is immune to 
subsequent infections by the same species (Yun et al., 2000).  Live oocyst vaccines may 
be comprised of attenuated or non-attenuated Eimeria strains.  Attenuation can be 
obtained by passing parasites through embryonated eggs or by selection for precocity 
(Williams, 2002).  Both non-attenuated and attenuated vaccines provide solid immunity 
to coccidial infection when applied carefully under good rearing conditions (Shirley and 
Long, 1990).  Live oocyst vaccination has been shown to be an effective tool for the 
generation of immunity and protection against subsequent Eimeria challenge evidenced 
by increased body weight gain (Danforth, 1998; Crouch et al., 2003; Williams, 2003), 
reduced feed conversion (Crouch et al., 2003), and reduced intestinal lesion development 
following Eimeria challenge (Danforth, 1998; Crouch et al., 2003; Williams, 2003).  Not 
all reports of live oocyst vaccine usage have been uniformly positive however, leading to 
a general reluctance in implementing vaccination programs in US broiler production due 
to reports of reduced performance (Allen and Fetterer, 2002a).  Non-attenuated vaccines 
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in broilers have been shown to decrease weight gain and increase feed conversion ratio 
as compared to medicated birds during starter period (Danforth, 1998; Williams, 2002).  
Other researchers have reported negative effects on cumulative broiler performance 
when using live oocyst vaccines compared to medication evidenced by reduced final 
body weights (Danforth et al., 1997; Waldenstedt et al., 1999a) and increased feed 
conversion ratios (Williams et al., 1999; Waldenstedt et al., 1999a).  This reported 
diminished performance was related to mild coccidia infection associated with live 
oocyst vaccination.  Other contradictory reports have indicated that vaccinated broilers 
performed similar to if not better than medicated broilers (Danforth, 1998; Williams and 
Gobbi 2002), and that vaccination can lead to significantly lower mortality rates 
compared to medication (Williams et al., 1999).   
Dietary manipulation has been shown to be an effective method of improving 
broiler performance during coccidial infection (Allen et al., 1998).  The manipulations 
reported to date focused mainly upon sources of fat containing high concentrations of n-
3 fatty acids and betaine.  Betaine is a naturally occurring, nontoxic amino acid 
derivative that functions as a dietary source of methyl groups and aids in cell volume 
regulation under osmotic stress (Saarinen et al., 2001).  Increasing dietary protein levels 
during periods of clinical coccidiosis has been shown to improve broiler performance 
(Sharma et al., 1973), but such a strategy to date has not been evaluated during 
vaccination.  Therefore, the proposed research program includes a series of five 
experiments with the following objectives:  
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1. To evaluate performance parameters affected by varying levels of dietary protein 
in starter diets of broilers vaccinated with a commercially available anticoccidial 
vaccine, Coccivac®-B1.  
2. To compare growth parameters of vaccinated and non-vaccinated broilers fed 
varying starter diet protein levels. 
3. To evaluate the effect of vaccination on the generation of immunity and 
protection against a subsequent mixed species Eimeria challenge measured by 
growth characteristics and intestinal lesion development. 
4. To compare effective live oocyst vaccination to the use of a common ionophore 
coccidiostat, salinomycin by measuring performance parameters in broilers fed 
two dietary rations varying in protein concentration.  
                                                 
1 Schering-Plough Animal Health, 556 Morris Avenue, Summit, NJ 07901-1330 USA 
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CHAPTER II 
LITERATURE REVIEW 
Life Cycle of Eimeria spp. 
 The life cycles of typical Eimeria spp. can be divided into three phases of 
development: sporogony, merogony, and gametogony (Hammond, 1973).  Sporogony 
usually takes place outside of the host.  Oocysts are the exogenous stages that are usually 
shed in the feces of a definitive host, and sporogony is the process by which a one celled 
sporont (zygote) within the oocysts wall undergoes a series of divisions to form 
sporozoites which either lie free in the oocysts wall or may be contained within 
sporocysts (Current et al., 1990).  For species that require sporogony outside of the host, 
environmental conditions must contain oxygen, moisture, and optimum temperatures.  
Only sporulated oocysts that contain sporozoites are infective to the definite host.  The 
route of infection is through oral ingestion by the bird.  Once ingested, the permeability 
of the oocyst’s environmentally resistant wall is altered by mechanical grinding in the 
ventriculus allowing sporozoites to be released from the sporocysts by the action of 
pancreatic enzymes, predominantly trypsin, and bile salts.  Trypsin acts to degrade the 
Stidea body which allows for the release of sporozoites into the intestine of the definitive 
host, while bile salts promote sporozoite activity and motility (Current et al., 1990).   
Once in the intestinal lumen, sporozoites travel to a species-specific site of 
infection and actively penetrate enterocytes and cells of the lamina propria.  Active 
penetration of sporozoites into host cells involves the organelles of the apical complex 
(Hammond, 1973).  Once inside the host cell, sporozoites round up into a uninucleate 
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meront and begin the second stage of development, merogony.  Merogony is the asexual 
proliferative phase of Eimeria spp. It is initiated when several mitotic nuclear divisions 
occur and is completed when elongated merozoites are released from the surface of the 
meront by multiple fission (Current et al., 1990).  Host cell damage inflicted by 
merozoites leaving the enterocyte, characterized by loss of host cell cytoplasm, proves to 
be a much more damaging act than the initial event associated with invasion of host cells 
by sporozoites (Hammond, 1973).  Once released from the host cell, free merozoites 
actively penetrate enterocytes near the initial site of infection and begin the next 
generation of asexual reproduction.  The number of asexual generations varies amongst 
individual Eimeria spp. and most have a characteristic number of asexual generations 
ranging from two to four (Current et al, 1990).   
Merozoites of the final generation of merogony enter host cells and initiate the 
sexual portion of the endogenous cycle (gamogony) by developing into male and female 
gamonts, the microgamonts and macrogamonts, respectively (Current et al., 1990).  
Microgamonts undergo nuclear divisions and ultimately results in the production of 
many microgametes that exit the host cell.  Microgametes contain a nucleus, two or three 
flagella, actively seek out, and penetrate host cells that contain mature macrogametes.  
Macrogamonts do not undergo nuclear divisions, but increase considerably in size within 
the host cell allowing for the proliferation of cellular organelles include wall-forming 
bodies that are involved in the subsequent formation of an oocyst’s wall (Current et al., 
1990).  The macrogamete is fertilized by the penetrating microgamete which results in 
the formation of a zygote.  Following fertilization, the environmentally resistant oocyst’s 
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wall is formed by the wall-forming bodies.  Oocysts are then released by the host cell 
and enter the environment.  The life cycle of Eimeria spp. will continue with sporogony 
of oocysts in the environment.  Eimeria have an enormous capacity to multiply in the 
intestine due to their complex life cycle.  One oocyst of E. tenella can give rise to more 
than 100,000 oocysts in a single generation (Chapman, 1993). 
Eimeria infection in poultry is host and site specific within individual species.  
Intestinal tissue damage caused by the different species of Eimeria will vary.  Eimeria 
acervulina and E. mivati will penetrate and cause lesions in the upper part of the small 
intestine (duodenum), E. maxima and E. necatrix cause lesions in the midgut (jejunum), 
and E. tenella and brunetti will cause lesions in the lower gut (ceca and large intestine) 
(Witlock and Ruff, 1977).   Sporozoites of E. acervulina penetrate the duodenum of 
chickens from a point just before the curvature of the loop to about 2.5 cm from the 
pancreatic duct (Doran, 1966).  Eimeria acervulina has been characterized as having 4 
asexual generations (Vetterling and Doran, 1966).  These generations are differentiated 
by merozoite production, size, and time after inoculation.  E. maxima has been shown to 
invade the anterior intestine (Joyner, 1982) and its meronts occur in the epithelial cells of 
the villi of the small intestine while its gamonts are displaced toward the center of the 
villi and come to lie in their interior (Levine, 1982).  E. tenella, the most pathogenic 
species in chicken, has three asexual generations within its life cycle and is localized to 
the villar epithelial cells and submucosa of the ceca causing hemorrhagic enteritis, and 
even death (Levine, 1982). 
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Structural changes due to coccidial infection are similar regardless of species.  
Common observations are villus flattening or atrophy, crypt hyperplasia, and decreases 
in villus to crypt ratios (Fernando et al., 1983; Morris et al., 2004).  Eimeria infections 
also cause varying degrees of malaise, diarrhea, nutrient malabsorption, reduction of 
growth rate (Allen et al., 1973; Witlock et al., 1975), and reduced intestinal viscosity 
(Waldenstedt et al., 2000).  Coccidia which infect and develop in crypt stem cells, 
particularly of the lower small intestine, cecum, and colon are highly pathogenic because 
they tend to destroy the crypt stem cells that they invade.  This destruction prevents 
renewal of villus epithelium resulting in the denuding of villi with attendant fluid loss, 
hemorrhage, susceptibility to bacterial invasion, and subsequent formation of necrotic 
lesions (Ruff and Allen, 1990).  Functionally mature epithelial cells of the intestine 
contain enzymes, such as disaccharidases, which are responsible for the terminal stages 
of digestion and provide the substrates for absorption (Eichholz and Crane, 1965).  
Increased mitotic activity leading to increased cell turnover is the most common change 
reported in coccidia infections (Ruff and Allen, 1990; Morris et al., 2004).  Goblet cell 
hyperplasia and increased numbers of enteroendocrine cells are also detected.  As such 
infections not only cause loss of absorptive area due to villar flattening, but the mucosal 
population also has a decreased percentage of functionally absorptive cells (Ruff and 
Allen, 1990).  Physical changes within each segment of the intestinal tract are 
summarized below. 
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Duodenum 
 The normal morphology of the duodenal villi range from fingerlike to spatulate-
shape while villi parasitized by E. acervulina are acutely truncated with no distinct tips 
as in normal intestines (Witlock and Ruff, 1977; Michael and Hodges, 1975).  Infections 
caused by E. mivati are not as severe and widespread as E. acervulina although infected 
birds have similar lesions.  The villar area which displayed morphological alteration was 
the tip of the duodenal villi in E. mivati infections and sloughing of the epithelium 
exposes the lamina propria (Witlock and Ruff, 1977).  In some observations made by 
Witlock and Ruff (1977), the entire villus tip was removed exposing the lamina propria 
core and oocysts were found within the damaged epithelial cells surrounding the lamina 
propria core.  Diminution of the mucosal layer in infected tissue becomes progressively 
more evident from 4-6 day post-infection, but by day 14 the intestine had recovered and 
appeared normal compared to uninfected birds (Allen and Danforth, 1984). 
Jejunum 
 Normal villi in this region are shorter, broader, and apically squared off versus 
villi of the duodenum.  E. maxima are reported to undergo development beneath the 
villar epithelium (Long, 1959).  Jejunal damage caused by E. maxima can vary from 
isolated patches of exposed connective tissue of the lamina propria to epithelial 
sloughing caused by E. maxima underlying the epithelial cells (Whitlock and Ruff, 
1977).  Oocyst formation of E. maxima occurs underneath the epithelium which may 
account for the large numbers of epithelial cells seen in the mucoid exudate 
characteristic of E. maxima infection (Whitlock and Ruff, 1977).  E. necatrix causes 
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damage by two distinct means: 1. the tips of the villi are eroded and large numbers of 
degenerating epithelial cells can be seen and 2. isolated villi are greatly enlarged with 
portions of lamina propria extruding through the villus tip as a result of pressure exerted 
by the large developing meront in the lamina propria (Whitlock and Ruff, 1977).  
Stockdale and Fernando (1975) reported similar observations during an E. necatrix 
infection of ruptured villar epithelium resulting in exposure of the lamina propria, which 
may allow leakage of blood components into the lumen causing blood streaked intestinal 
contents.  
Ileum, Large Intestine, and Ceca 
Uninfected villi of the ileum appear apically pointed, compact, and differ only 
slightly from those of the large intestine that are blunter, wider, and thicker (Whitlock 
and Ruff, 1977).  E. brunetti causes severe damage in both the ceca and large intestine 
while E. tenella causes most damage to the ceca.  Almost immediately after invasion of 
merozoites into crypt epithelium cells by E. tenella, the cells begin the sequence of 
morphological changes including swelling and loss of microvilli, leading to 
transformation within the lamina propria into giant cells with giant nuclei (Fernado et al., 
1983).  During an E. brunetti infection, the villi of both the ileum and large intestine are 
completely disrupted and eroded, exposing the underlying connective tissue of the 
lamina propria causing extensive coagulation necrosis with accompanying sloughing of 
the mucosa (Whitlock and Ruff, 1977).  Villar morphology is completely lost with the 
disassociation of the epithelial cells and sloughing while E. brunetti can be seen 
embedded in the tissue debris (Whitlock and Ruff, 1977).  E. brunetti causes extensive 
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damage to the intestinal mucosa which may account for the mortality associated with 
this infection. 
Damaged to the intestine caused by Eimeria spp. is thought to be involved in 
increasing the susceptibility of chickens to outbreaks of necrotic enteritis (NE) caused by 
Clostridium perfringens Type A and C (Williams et al., 2003), and cases of NE 
associated with Clostridium perfringens have increased in countries that have stopped 
using antibiotic growth promoters (Van Immerseel et al., 2004; Williams, 2005).  The 
acute form of NE leads to increased mortality in broiler flocks which can account for 1% 
mortality losses per day for several consecutive days during the last weeks of the rearing 
period (Van Immerseel et al., 2004).  Experimental models developed to initiate NE in 
broilers usually involve some form of infection with an Eimeria spp. to cause intestinal 
damage and allow for Clostridium perfringens establishment and proliferation in the 
intestine which often coincides with peak coccidial infection (Al-Sheikhly and Al-Saieg, 
1980; Williams et al., 2003; McReynolds et al., 2004).  In the model developed by 
Williams et al. (2003), a virulent coccidial challenge with E. maxima sufficient to cause 
clinical coccidiosis exacerbated a virulent clostridial challenge.  Williams et al. (2003) 
also observed reduced NE lesion development following a virulent clostridial challenge 
in Paracox-5 vaccinated broilers due to preventing severe coccidial lesions that might 
predispose birds to NE. 
Physiological Changes in the Intestinal Epithelium during Coccidiosis 
Coccidial infections in poultry have been shown to decrease the growth rate of 
chickens by 15 to 20% during mild coccidiosis and up to as much as 30 to 40% during 
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severe coccidiosis (Willis and Baker, 1981a).  This period of decreased growth rate is 
followed by period of compensatory growth during the recovery from the infection 
(Panda and Combs, 1964).  As a result of this increased growth rate, birds recovering 
from coccidial infections frequently grow rapidly enough that their body weight catches 
up to that of non-infected birds, although it takes considerable time for this 
compensatory growth to occur (4-6 weeks post-infection) (Turk, 1974).  In the case of 
chronic infections where doses of the infective parasite are given over a period of several 
days, both the period of absorption impairment as well as the period of above normal 
nutrient absorption are prolonged (Turk and Stephens, 1970).  The time interval required 
for infected chickens to undergo compensatory gain so as to equal gain measured in 
uninfected broilers is probably different at present, as the broiler of 2006 is extremely 
different in terms of genetic make-up than the broiler of 1974.   
Intestinal damage due to a coccidial infection will first become visible on the 4th 
or 5th d post-infection.  The most severe and widespread lesions will occur on the 6th and 
7th d post-infection, and complete resolution or healing will be evident by the 14th to 21st 
d post-infection (Turk, 1974).  The following sections will discuss the physiological 
changes (enzyme activity and nutrient absorption) that take place in each section of the 
intestine during an infection and discuss the compensatory effects associated with other 
segments of the small intestine during an infection.   
Duodenum 
 Eimeria acervulina is the primary species that affects the small intestine of 
chickens.  There have been several reports describing the changes in gut physiology 
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which occur during an E. acervulina infection.  Infection with E. acervulina during the 
acute phase of the disease (d 4 to d 8 post-infection) causes a significant reduction in the 
retention of percent protein, percent ether extract and percent gross energy of the diet 
with a concomitant significant increase in the concentration of ether extract and gross 
energy of the excreta (Sharma and Fernando, 1975).  Coccidial infections of the 
duodenal loop markedly affect zinc, oleic acid, and calcium absorptions while effects on 
sulfur amino acid requirements (Willis and Baker, 1981b), protein and amino acid 
absorption were minimal (Turk, 1974).  Other reports contradict Turk (1974) with 
respect to amino acid and protein absorption.  Sharma and Fernando (1975) and Ruff et 
al. (1976) observed significant reductions in both protein and amino acid absorption 
rates during E. acervulina infection.  Ruff et al. (1976) observed significant reductions in 
methionine absorption in the duodenum of E. acervulina challenged chickens compared 
to levels of non-challenged and E. tenella challenged chickens.  Ruff and Wilkins (1980) 
reported similar observations of decreased glucose and methionine absorption during 
both E. acervulina and E. mivati infections.  Reductions in amino acid digestibility were 
recently confirmed by Persia et al. (2006), while also reporting a reduction in 
metabolizable energy levels of diets in E. acervulina infected chickens. 
Turk and Stephens (1967a) reported that absorption of zinc and oleic acid was 
typically increased at the beginning of the infection, and markedly dropped as the 
infection proceeded toward the acute phase, reaching a minimum at the time of the most 
severe intestinal damage (inflamed duodenum and general lack of muscle tone).  Zinc 
and oleic acid absorption levels were reduced to 25-40% of that of uninfected birds, but 
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about the time that visible intestinal damage was repaired absorption rates for zinc and 
oleic acid increased to levels well above those occurring in the uninfected birds (Turk, 
1974).  Zinc absorption rates of birds that had recovered from coccidial challenge were 
roughly double when compared to uninfected birds while oleic acid levels increased 
25% compared to uninfected birds.  These increased levels of absorption were 
maintained for two weeks which corresponds with the time period of compensatory 
growth seen in coccidial challenged birds (Turk, 1974).  Compensatory gain of broilers 
infected with E. acervulina was also observed by Adams et al. (1996a) between 6 and 12 
d post-infection which followed a period of depressed growth from 3 to 6 d post-
infection. 
E. acervulina infection also slows the rate at which nutrients enter the 
bloodstream through the lumen of the intestine (Turk and Stephens, 1967a).  The 
interference of nutrient absorption has been attributed to the reduced levels of plasma 
carotenoids observed in E. acervulina infected chickens (Ruff and Fuller, 1975).  The 
maximum amount of oleic acid appeared in the bloodstream at or after 8 h post-ingestion 
in challenged birds while it appeared between 1 and 2 h post-ingestion in non-challenged 
birds.  Partial responsibility for delayed absorption is due to decreased gut motility 
(Aylott et al., 1968).  Turk (1974) hypothesizes that decreased digestive tract motility 
may be responsible for the increase in nutrient absorption that is seen for the first three 
days of infection.  This slow digestive tract rate would permit the nutrients to be in 
contact with the intestinal mucosa for a longer period of time.   
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Liver glycogen levels are also significantly reduced during the acute phase (5-6 d 
post-infection) of an E. acervulina infection followed by significantly increased levels 
during the recovery phase (6-8 d post-infection) (Ruff and Allen, 1982).  Allen and 
Danforth (1984) also observed reduced rates of glucose and octanoic acid oxidation in 
infected birds.  Mitochondria isolated from infected birds oxidized both octanoic and α-
ketoglutaric acids at lower rates than mitochondria from control chickens (Allen and 
Danforth, 1984).  The reduced rates of these reactions in mitochondria from infected 
epithelial tissue indicate that Eimeria acervulina caused some kind of mitochondrial 
lesion associated with the matrix or inner membrane (Allen and Danforth, 1984).  Allen 
and Danforth (1984) observed a shift in metabolism due to coccidial infection in the 
duodenum by E. acervulina.  E. acervulina infection caused a four-fold increase in the 
ratio of metabolism of glucose through the glycolytic pathway versus the tricarboxylic 
acid (TCA) pathway at d 4 post-infection.  These findings indicate a shift in metabolism 
away from mitochondrial oxidation towards oxidation of glucose through the pentose 
phosphate pathway (Bloom and Stetten, 1953). 
 Periods of malabsorption observed in chickens have been attributed to epithelial 
destruction through Eimeria infection.  Allen reported (1987) significant reductions in 
total mucosal dry weights of upper intestinal segments from Eimeria acervulina infected 
chicks compared to controls at d 3, 5, and 7 post-infection while the lower segment 
significantly increased in total mucosal dry weight by d 7 post-infection.  These findings 
agree with reports of increased ileal length at 4 d post-infection as well as increased 
fresh and dry weight at 7 days post E. acervulina infection (Allen, 1984).  Allen (1984) 
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also observed increased fresh and dry weights of jejunal segments during E. acervulina 
infection although increased jejunal weights were not observed during severe infections.  
E. acervulina infection also decreased total alkaline phosphatase and sucrase activity in 
the upper and middle segments compared to controls at 3, 5, and 7 d post-infection 
(Allen, 1987).  Decreased maltase and sucrase activity in the duodenum at 5, 6, and 7 d 
post-infection with E. acervulina have also been reported (Major and Ruff, 1978; Adams 
et al., 1996a).  Maltase (Adams et al. 1996a) and sucrase (Allen, 1987) activity 
significantly increased in the ileum 7 d post-infection with E. acervulina.  At 7 d post-
infection, more mucosal cells were recovered from ileal segments from infected chicks 
than from controls (Allen, 1984)  Whole cells and mitochondrial preparations of these 
cells oxidized octanoic acid at higher rates than did controls (Allen, 1984).  The 
increased mass and metabolic activity of the more distal portions of the small intestine 
provides a means for compensatory absorption of nutrients during E. acervulina 
infection (Allen, 1984). 
The periods of time of either impaired or compensatory nutrient absorption 
correspond directly with the changes in mitochondrial structure of the mucosal cells.  
During the first 10 days of infection, mitochondria from infected birds swelled and 
appeared to lose their internal structure with increased numbers of sickle and dumbbell-
shaped mitochondria (Turk, 1974).  These mitochondria were most numerous on d 6 
post-infection or at the time of greatest absorption impairment.  During the recovery 
phase, mitochondria appeared to resume normal shape and function, and many 
developed rod-like extensions from the body of the mitochondria.  After recovery from 
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E. acervulina infection (d 21 post-infection), mitochondria were larger than normal, 
coincided with compensatory nutrient absorption, and then regressed to normal size 
(Turk, 1974).  Allen and Danforth (1984) also found that mitochondrial structure 
changed throughout Eimeria acervulina infection.  Mitochondria of parasitized cells did 
not alter in appearance but non-parasitized cells recovered from infected birds differed 
considerably from mitochondria recovered from uninfected birds.  Non-parasitized cells 
from infected birds contained mitochondria that were swollen on d 5 and 6 post-infection 
(Allen and Danforth, 1984), possibly indicating increased activity of non-parasitized 
cells in infected animals. 
Jejunum 
 Two main Eimeria species parasitize the jejunum of the bird (Eimeria maxima 
and Eimeria necatrix).  Infections of either species caused decreased absorption of 
nutrients and physiological changes in the jejunum.  E. maxima infection depressed feed 
intake and reduced body weight gain during the acute phase of infection (5-7 d post-
infection) compared to pair-feeding controls (Chapman et al., 1982).  E. maxima also has 
been related to decreased glucose and methionine absorption in the jejunum 7 d post-
infection (Ruff and Wilkins, 1980).   E. necatrix infection in broilers caused decreased 
zinc (Turk and Stephens, 1966) and protein absorption (Turk, 1972) while calcium 
(Turk, 1973), oleic acid (Turk and Stephens, 1967b), and amino acid absorption was less 
or unaffected (Turk and Stephens, 1969).  Patterns of zinc and protein digestion and 
absorption patterns were similar to patterns observed in the duodenum throughout the 
infection.  Increased zinc absorption was observed during the first three days post-
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infection and returned to normal rates after the recovery phase (Turk, 1974).  Protein 
absorption remained equal to uninfected birds for the first three days but dramatically 
dropped at d 6 post-infection (58% level of controls) and returned to levels significantly 
increased (171% level of controls) to uninfected birds upon recovery resulting in 
compensatory gain (Turk, 1974).  The decrease in protein digestion and absorption was 
only observed during jejunal infections while absorption of amino acids was not affected 
when fed as individual amino acids.  Zinc absorption rates were more significantly 
reduced during a jejunal infection dropping to a rate 34% observed in the controls (Turk 
and Stephens, 1966).  Oleic acid and calcium absorption were affected to a lesser extent.  
Jejunal infections reduced oleic acid and calcium absorption to a level 65% to the 
control which suggests the duodenum has an increased role in fat digestion as compared 
to the jejunum (Turk, 1974). Jejunal infections dramatically impair the bird’s ability to 
digest proteins, absorb amino acids, and zinc indicating the jejunum’s role in the 
digestion of proteins and absorption of zinc. 
 Infection with E. mitis caused malabsorption of glucose and methionine in the 
region of the yolk sac diverticulum up to 52% of control levels (Ruff and Edgar, 1982).  
Reduced absorption became evident 3 d post-infection, continued through 5 d post-
infection although no visible lesions were evident except reduced body weight of 
challenged chickens. 
Ileum, Large Intestine, and Ceca 
 Coccidial infections of the ileum, ceca, and large intestine are primarily caused 
by E. tenella and E. brunetti.  E. tenella or E. brunetti infections cause significantly 
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reduced liver glycogen levels in broilers (Ruff and Allen, 1982).  E. brunetti caused a 
decrease in calcium (Turk, 1973), glucose, and methionine absorption rates in the ileum 
during peak infection (Ruff and Wilkins, 1980).  Similar to the other sections of the 
small intestine, increased absorption rates were observed for nutrients during the first 
three days of the infection and again following the recovery phase.  During an E. tenella 
infection (localized to the ceca), only minute changes were seen in absorption rates of 
calcium, oleic acid, zinc, and amino acids (Turk, 1972), indicating that E. tenella 
infections have little affect on most nutrient absorption (Turk, 1974).  Witlock (1982) 
observed significantly increased mucosal wet and dry weights of the lower intestine as 
early as 4 d post-infection over control birds, corresponding with a twofold increase in 
mucosal thickness and muscular thickness.  Coccidial infections lead to increased total 
mucosal dry weights on d 7 post-infection versus 3 and 5 d post-infection indicating an 
increase in epithelial cell proliferation rate (Allen, 1987). 
 Conway et al. (1993) observed E. tenella infection significantly reduced plasma 
carotenoids, lipids, and proteins as well as body weight gain and feed efficiency.  Ruff 
and Fuller (1975) determined that reduced carotenoid levels during E. tenella infection 
were associated with leakage through the damaged wall of the cecum.  These data 
suggested that E. tenella has an effect on nutrient absorption which contradicts Turk 
(1974), although Conway et al., (1993) did not measure nutrient absorption.  Plasma 
carotenoid, lipid, and protein levels may be reduced by another mechanism such as 
anorexia or bleeding through the gross lesions associated with an E. tenella infection.  
Baba et al. (1993) observed increased mannose residues present on the cecal mucosa 
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which may allow adhesion of more Type 1 fimbria Salmonella to colonize the intestine 
during an E. tenella infection, an action which potentially has implications on human 
food safety, as described by Kogut et al. (1994).   
Host Immune System 
The complete immune response of chickens to either a primary or secondary 
infection with coccidia is very complex and involves cells from both innate and specific 
systems.  All Eimeria species induce an acquired immune response that includes both 
humoral and cell mediated components.  It is mainly accepted that cell mediated 
components comprise the majority of the immune response resulting in immunity 
generation.  Because Eimeria are intestinal parasites, the gut-associated lymphoid tissue 
(GALT) is the first line of defense against infection.  The GALT is a multi-layered tissue 
continuously exposed to food antigens, the normal microbial flora, and ingested 
pathogens (Yun et al., 2000).  The outer layer of the GALT consists of epithelial cells 
and lymphocytes situated above the basement membrane.  The lamina propria lies below 
the basement membrane and contains lymphocytes and the submucosa (Yun et al., 
2000).  The GALT contains many cell types (epithelial, lymphoid, antigen presentation 
cells, and natural killer (NK) cells) in specialized lymphoid organs (Peyer’s Patches, 
cecal tonsils, and the bursa of Fabricius).  There are three general functions of the GALT 
in a host defense against pathogenic infections including coccidiosis: 1. processing and 
presentation, 2. production of intestinal antibodies, and 3.activation of cell-mediated 
immunity (Brandtzaeg et al. 1987).  Twenty-five percent of the intestinal mucosa is 
composed of lymphoid tissues, which appear as discrete or aggregated lymphoid 
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follicles or as scattered lymphocytes in the intestinal epithelium, lamina propria, or 
lymph (Mowat and Viney, 1997).  Cellular communication networks within the GALT 
are bi-directional with lymphocyte secreting and responding to cytokines that stimulate 
or inhibit the activities of other lymphocytes and non-lymphoid cells (Yun et al., 2000). 
The specialized lymphoid organs present in the GALT allow for a site of antigen 
interaction with immune cells of the host.  Peyer’s patches are nodules of lymphoid 
tissue in the submucosa of the intestine overlaid by a specialized epithelium. This 
epithelium provides an important site for contact between foreign antigens and lymphoid 
tissues, and contains B cells, T cells, and antigen presenting cells (Yun et al., 2000).  
Peyer’s patches have been characterized by Burns (1982) as having thickened villi, 
flattened epithelium lacking goblet cells, accumulation of lymphocytes in encapsulated 
germinal centers, and diffuse lymphoid tissues.  Peyer’s patches contain Microfold (M) 
cells that allow for antigen uptake and the initiation of immune responses.  M cells lack a 
developed microvillus border and glycocalyx coat allowing free access to luminal 
pathogens (Yun et al., 2000).  Lectin-like molecules on the surface of M cell serve as 
selective binding sites for pathogens. M cells deliver antigens from the lumen of the 
intestine directly to intraepithelial lymphocytes and subepithelial macrophages by an 
active transepithelial vesicular transport system (Gebert, 1997). 
Cecal tonsils are located at the ileocecal junction and are the major lymphoid 
tissue in the cecum of the chicken.  Cecal tonsils constitute the largest collection of 
GALT in the chicken with the lymphocyte profile containing 45-55% B cells and 35% T 
cells indicating a role in both antibody production and cell mediated immune functions 
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(Yun et al., 2000).  The cecal tonsil’s immunological maturation and overall size are 
dependent on the degree of antigenic stimulation with increasing numbers of 
lymphocytes appearing as a function of age due to migration caused by antigen 
stimulation (del Cacho et al., 1993).  Continuous backflow from the urodaeum of the 
cloaca stimulates the cecal tonsils with new antigen.   
Epithelial Cells 
Historically, epithelial cells have been regarded as passive cells with three main 
functions: 1. absorb essential nutrients from digested foods; 2. compose a major part of 
the first line of defense against ingested pathogens due to their constant contact with the 
external environment; and 3. undergo continuous cycle of cell death and regeneration, 
thereby eliminating cells damaged by the digestive process or harmful environmental 
agents (Yun et al., 2000).  Recently, reports have indicated that epithelial cells are 
important regulators of natural and acquired immunity by the secretion of chemicals and 
cytokines (McGee et al., 1993; Panja et al., 1995; Reinecker et al., 1997).  Normal 
intestinal epithelial cells can process soluble polypeptides and activate CD8+ T cells 
with the expression of antigen with major histocompatibility complex (MHC) class I 
molecules.  It has been reported that intestinal epithelial cells can express MHC class II 
molecules (Bland, 1988) and present soluble antigens to CD4+ T cells (Kaiserlian et al., 
1989).  Epithelial cells are poor antigen presenting cells because they are unable to 
express critical co-stimulatory molecules needed for CD4+ T cell activation (Sanderson 
et al., 1993).  With the lack of co-stimulatory molecules present on the epithelial cells, 
interactions between intestinal epithelial cells and CD4+ T cells may result in anergy.   
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Intestinal epithelial cells provide early signals important for initiation and 
regulation of the inflammatory response following parasitic invasion at the intestinal 
surface.  Following invasion, epithelial cells produce several cytokines including IL-1, 
IL-6, IL-8, Tumor Necrosis Factor (TNF)-α (Panja et al., 1995), prostaglandins, and 
complement cascade components (Keelan et al., 1998).  These cytokine secretions cause 
chemotaxis of innate and specific immune cells to the site of infection, and aid in the 
initiation of the inflammatory response.  While intestinal epithelial cells are central to 
the intestinal immune response, the role of intestinal epithelial cells in Eimeria infections 
is largely unknown. 
Cells of the Innate Immune System 
Innate immunity is responsible for the elimination of parasites during the early 
phase of primary infection (Lillehoj and Trout, 1994).  Macrophages, one of the 
professional antigen presenting cells, process soluble antigens into immunogenic 
peptides, display appropriate peptide-major histocompatibility complexes (MHC) on 
their surface, and express costimulatory molecules (B7-1 and B7-2) to amplify T cell 
activation (Yun et al., 2000).  Macrophages have the capacity to synthesize and secrete 
the largest number of communication or signaling molecules of any cell type 
(Oppenheim and Shevach, 1990).  These cytokines play a major role in the up regulating 
and coordinating a complete immune response.  Upon ingestion of Eimeria acervulina 
oocysts, significant numbers of sporozoites are found within macrophages following 
both primary and secondary infections (Vainio and Lassila, 1989; Trout and Lillehoj, 
1995).  Macrophage phagocytosis in immune chickens depends on Eimeria species.  
  
25
Increased macrophage uptake of E. tenella sporoziotes in immunized chicks has been 
observed but the same trend does not exist with respect to E. acervulina.  Increased 
macrophage uptake of E. acervulina sporozoites in E. acervulina immunized chicks did 
not occur (Onaga and Ishii, 1980).  Macrophages from immune hosts were activated and 
digest sporozoites in a complement dependent mechanism (Bekhti and Pery, 1989) and 
sporozoites stimulated macrophages produced increased amounts of TNF-α (Zhang et 
al., 1995).  Thus, macrophages modulate the host response to Eimeria spp. through 
production of these soluble mediators (Lillehoj and Trout, 1996).  However, 
macrophages may induce pathology by mediating an over amplified inflammatory 
response against foreign agents.  Local intestinal pathology results from degranulation 
products, reactive oxygen intermediates, and lysosomal enzymes released by activated 
leukocytes (Klasing, 1991).   
 Several characteristics of mast cell function illustrate the importance of these 
cells as integral mediators of mucosal immune responses (Caldwell et al., 2004).  Mast 
cell characteristics include: 1.the location of intestinal mast cells at the interface between 
the external and internal environments of the animal; 2. the capacity of mast cells to 
release pro-inflammatory and anaphylactic mediators; 3. and the capacity of the cells to 
undergo multiple cycles of mediator release during prolonged responses in the intestine 
(Abraham and Arock, 1998).  Mucosal mast cells have been observed to increase in 
number and activity during Eimeria challenge (Caldwell et al., 2004; Morris et al., 
2004).  Morris et al. (2004) observed significantly increased mast cell counts on d 3 and 
4 post-Eimeria acervulina challenge.  In rats, increased mast cell counts during Eimeria 
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challenge led to increased release of soluble serine protease (Huntley et al., 1985).  
Petrone et al. (2002) observed increased numbers of mast cells during the acute 
inflammatory response caused by E. tenella.  Although this evidence indicates that mast 
cells may play an integral role in the immune response to Eimeria, there is a lack of 
research to completely identify the precise role.  A Factor that compounds the evaluation 
of mast cell activity is the difficulty of identification due to mast cell degranulation 
before or during fixation of the tissues not allowing the absorption of the stain (Morris et 
al., 2004). 
 NK cells are a sub-population of lymphocytes which lack the antigenic 
specificity of B- or T-lymphocytes and exhibit spontaneous cytotoxicity against a wide 
variety of target cells (Reynolds and Ortaldo, 1989).  NK cells may constitute an active 
part of the first line of defense in the intestine because of their close proximately to sites 
where antigens are introduced.  The intestinal epithelium of chickens contains a 
subpopulation of NK cells that mediate spontaneous cytotoxicity.  This indeed suggests 
that they are an important component to intestinal immunity during coccidiosis (Lillejoh, 
1989).  Their effects are mediated by several mechanisms including: 1. secretion of 
immunoregulatory cytokines (including Interferon-γ); 2. lysis of parasitized host cells; 
and 3. direct inhibition of the growth of microorganisms via interactions with T cells 
(Bancroft, 1993).  Increased NK cell activity in Eimeria inoculated chickens has been 
shown to occur during the later phase of a primary infection (8 d post infection) which 
correlates with the time of reduced oocyst production (Lillehoj, 1989).  NK cell activity 
significantly increases at 1 and 3 d post-infection upon secondary infection (Lillehoj, 
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1989; Lillejoh and Lillejoh, 2000).  Lillehoj (1989) determined that NK cells may be 
involved in immuno-surveillance against and in the elimination of Eimeria spp. 
following infection.  Increased NK cell activity is accompanied by increased number of 
intraepithelial lymphocytes expressing CD8+ receptors (Lillehoj and Bacon, 1991). 
Cells of the Specific Immune System 
  The principal cells of specific immunity are B and T cells with each cell type 
obviously being responsible for various functions during the generation of immunity in 
an animal.  Depending on the properties of the pathogen, the specific system will utilize 
a humoral response, cell-mediated response, or a combination of the two in order to clear 
the pathogen from the body.  Within the intestinal mucosa, lymphocytes are present in 
two anatomic compartments: epithelium and lamina propria (Befus et al., 1980).  Many 
researchers have concluded that while both immune responses are present during 
Eimeria infections, cell-mediated immunity is the predominant response responsible 
during coccidiosis while humoral immunity plays a minor role (Lillehoj and Trout, 1996; 
Brake et al., 1997b; Lillehoj and Lillehoj, 2000; Yun et al., 2000; Allen and Fetterer, 
2002a). 
The importance of T cells in the immune response to Eimeria has been heavily 
investigated to identify their role in generating immunity against coccidiosis.  As in 
mammals, chicken T cells can be phenotypically separated into CD4+ (helper/inducer T 
cells) and CD8+ (cytotoxic/suppressor T cells) subpopulations (Lillehoj and Trout, 
1994).  Further divisions of these subpopulations are based on two different TCR 
molecules, αβ or γδ TCR.  T helper cells are responsible for assisting with both antibody 
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synthesis and delayed-type hypersensitivity, whereas T cytotoxic cells mediate 
cytotoxicity (Lillehoj and Trout, 1994 Turk (1974).  T cytotoxic cells recognize foreign 
antigen in the context of MHC class I molecules and T helper cells recognize antigens in 
association with MHC class II molecules (Lillehoj and Trout, 1994).  In contrast to T 
cells in the peripheral blood, 75-80% of intraepithelial lymphocytes express the CD8+ 
phenotype while only 5-15% posses the CD4+ phenotype (Selby et al., 1984) and 50% 
of the CD8+ intraepithelial lymphocytes may express the γδ TCR (Jarry et al., 1990).  
The concentration of CD8+ T cells in intestine is presumably higher because most 
parasites are ingested so CD8+ T cells can come in contact with intracellular parasites at 
this location.  Activation of γδ TCR cells may be inherently unique and separable from 
that of αβ TCR cells because γδ TCR cells may recognize non-peptide ligands which do 
not stimulate αβ TCR cells (Tanaka et al., 1995).  Therefore, γδ TCR cells can mediate 
specific cellular immune functions without the requirement for antigen processing 
allowing recognition of invading pathogens and damaged cells directly (Schild et al., 
1994). 
Cell mediated immune responses are the most effective immune response against 
intracellular parasites such as Eimeria (Bessay et al., 1996).  Cell mediated immune 
responses include both antigen specific activation of T cells and non-specific activation 
of NK cells and macrophages.  Eimeria infection seems to rapidly induce, locally at the 
site of the parasite development, a dramatic modification of the proportion of T-cell 
subsets in intraepithelial leukocytes, accompanied by systemic variations that are 
generally opposing, in the lymphocyte populations (Bessay et al., 1996).  Increased 
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numbers of αβ CD8+ T cells are observed following primary exposure to coccidia with 
significantly increased αβ TCR and γδ CD8+ T cells upon secondary exposure to E. 
tenella (Vervelde and Jeurissen, 1995; Bessay et al., 1996).  Increased levels of CD8+ T 
cells were related to decreased numbers of oocysts shed (Bessay et al., 1996).  Eimeria 
challenge caused increased percentages of CD4+, CD8+, and γδ TCR percentages in the 
intestine (Bessay et al., 1996).  During E. maxima challenge, increased T lymphocyte 
levels were associated with two peaks.  The first peak taking place on d 3 to 5 post-
infection and the larger second peak taking place on d 11 (Rothwell et al., 1995).   
Increased T-cell subpopulations (CD4+ and CD8+) and TCR markers (γδ and αβ) were 
observed in both peaks with CD4+ cells exclusively in the lamina propria and CD8+ in 
the lamina propria and the epithelium (Rothwell et al., 1995). 
Investigations aimed at understanding the cell mediated immune response to 
coccidiosis utilized two inbred lines of chickens; one line more resistant (SC) to 
coccidial infection and one line more susceptible (TK) to coccidial infection.  CD4+ T 
cells increased significantly and more rapidly post primary infection in SC chickens 
compared to TK chickens (Choi et al., 1999).  Increased CD8+ T cells were observed in 
both strains of chickens following primary infection and a continued increase in SC 
chickens was observed with a marked decrease in TK chickens as the infection persisted 
(Choi et al., 1999).  Intestinal CD4+ and CD8+ T cells isolated from regions of the 
intestine infected with coccidia produced elevated IFN-γ mRNA and protein during the 
early phase of infection (Choi et al., 1999).  This cytokine plays an important role in the 
recruitment and up regulation of macrophages to secrete IL-2 causing clonal expansion 
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of activated T cells.  These investigations indicate that CD8+ T cells are important in 
protection against coccidiosis and that genetic variation within different strains of birds 
can result in different localized changes in T cell subpopulations during coccidiosis.   
 The intestine is the largest immunological organ in the body containing 70-80% 
of all immunoglobulin-producing cells with external intestinal secretions predominantly 
consisting of mainly IgA and IgM (Yun et al., 2000).  The majority of IgA in the 
intestinal lumen is produced by plasma cells in the lamina propria and transported across 
epithelial cells.  IgA inhibits colonization of microorganisms in the intestinal lumen and 
neutralizes intracellular viruses as it passes through the epithelial cell.  Chickens infected 
with Eimeria produce parasite specific IgM, IgY, and IgA antibodies in the circulation 
and mucosal secretions. Increased parasite specific antibody production by intestinal B 
cells shortly after infection with coccidiosis has been documented (Lillejoh and Lillejoh, 
2000).  Significantly increased sIgA and biliary IgA are detected within a week of oral 
infection and reached maximal levels around 8-14 days later persisting an additional 2 
months (Lillejoh and Ruff, 1987).  SIgA levels are significantly higher in intestinal 
regions that are parasitized versus non-parasitized indicating humoral activation against 
the parasite (Girard et al., 1997).  Antibodies may serve an indirect role in immunity by 
reducing infectivity as a consequence of parasite agglutination, neutralization, steric 
hindrance, reduced motility, induction of conformational changes in the parasite’s host 
cell receptor molecules, and inhibition of intracellular parasite development (Lillehoj 
and Lillehoj, 2000).  However, the role of humoral immunity in response to coccidiosis 
has been readily debated.  Agammaglobulinemic chickens produced by hormonal and 
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chemical bursectomy verify that parasite specific antibodies are not required for 
resistance to reinfection with coccidia (Lillehoj, 1987).   
Cytokine production plays an important role in mounting a complete and full 
immune response of both the innate and specific systems.  IFN-γ stimulates proliferation 
and differentiation of hematopoietic cells and enhances nonspecific immunity to 
parasites (Lillejoh and Lillejoh, 2000).  IFN-γ regulates specific immunity by enhancing 
expression of MHC class II antigens and has been used as measure of cell mediated 
response to coccidiosis (Choi et al., 1999).  IFN-γ has potent effect on macrophage 
activation by inducing macrophage cytostatic activity and induction of macrophage 
nitric oxide production by oxygen dependent mechanism.  In Eimeria infected chickens, 
SC chickens (more resistant strain) produced greater amounts of nitric oxide compared 
with infected TK chickens (less resistant strain) (Lillehoj and Li, 2004).  The production 
of nitric oxide, a highly active free radical, has been correlated with increased lesion 
development during coccidiosis outbreaks (Allen, 1997).  Peaks in nitric oxide 
production correspond to the time when mucosal damage is the highest indicating that 
intestinal lesion development is in part due to the host immune response (Lillejoh and 
Lillejoh, 2000).   
While IFN-γ has a potent role in a host immune response, several other cytokines 
are secreted as well.  Transforming Growth Factor (TGF)-β is another cytokine produced 
by chickens in response to Eimeria infection.  Three different isoforms of TGF-β have 
been identified: β1, β2, and β4.  TGF-β4 has been observed to increase 5 to 8 fold during 
coccidiosis.  TGF-β4 may play a role in promoting growth of the intestinal villi with 
  
32
high levels corresponding to periods of increased cell proliferation. TNF-α production 
which is secreted by macrophages follows a biphasic pattern, with the first peak 
corresponding to disease pathogenesis and the second peak associated with the 
development of protective immunity (Byrnes et al., 1993).  IL-1 production during 
infection with E. maxima or E. tenella is constant with identical concentrations 
regardless of oocyst dose (Byrnes et al., 1993).  Secretion of IL-15 by macrophages 
serves to promote γδ-CD8+ T cells and NK proliferation and activation.  These cytokine 
activities play an important role in immunity to coccidiosis (Choi et al., 1999). 
 Since the complete immune response to a coccidial infection is so complex, there 
are many aspects of the response that are poorly understood.  Overall, the immune 
response is extremely comprehensive consisting of innate and specific responses with 
cooperativity between both segments of the immune system.  Future research is needed 
to identify the exact role of the innate and specific systems in the immune response and 
the exact responsibility each plays.   
Cross Species Protection 
Host immunity is species specific, and little to no cross-protection is observed 
against heterologous species (Lillejoh and Lillejoh, 2000) and in some cases different 
strains of the same species (Shirley, 1989).  Lillehoj (1986) showed that cells from 
chickens which were immune to E. tenella responded well to antigens from E. tenella 
but poorly to E. acervulina antigens suggesting that the lack of cross-protection may be 
due to the absence of cross-reactive T cells.  Prowse (1991) observed increased 
interferon production in spleen cells from E. tenella immunized birds four to eight times 
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greater to E. tenella antigen compared to E. acervulina antigen.  However, interferon 
production in spleen cells from E. acervulina immunized birds was similar in response 
to both E. acervulina and E. tenella antigens.  Prowse (1991) determined that the lack of 
cross species protection is not due to the lack of cross-reactive T cells and suggested that 
there must be other factors involved in the expression of resistance.  E. maxima is the 
most immunogenic of the avian Eimeria species and has been shown to exhibit a much 
higher degree of immuno variability as compared to other Eimeria species.  Increased 
immuno variability of E. maxima may provide the basis for observed lack of cross-
protective immunity among geographically isolated strains (Martin et al. 1997; Barta et 
al., 1998).  Allen et al. (2005) determined that Eimeria fecundity is important in 
providing good immune stimulation and should be carefully monitored when 
characterization of the unique immune potentials of Eimeria strains is performed.   
Williams (1973) observed that chicken flocks that were heavily infected with E. 
acervulina were often lightly infected with other species. During simultaneous 
inoculation of E. acervulina with E. brunetti, E. maxima, E. tenella or E. necatrix 
resulted in lower oocyst production by all of the species except E. acervulina compared 
to oocyst production during individual infections (Williams, 1973).  In chickens 
immunized with E. acervulina, challenge doses of E. acervulina have a slight 
enhancement of invasion compared to naïve chickens (Augustine and Danforth, 1986).    
Augustine (1996) observed enhanced invasion by E. tenella in E. acervulina immunized 
chickens compared to naïve chickens although no effect was observed during 
simultaneous infection with E. acervulina and E. tenella.  While the enhanced invasion 
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of sporozoites of the immunized species is not of concern because subsequent 
development by the sporozoites would be limited.  The invasion enhancement of other 
Eimeria species is of concern because of the lack of the immunity to this species which 
may lead to increased disease.  Vaccines may protect against challenge with the target 
species but, at the same time, actually amplify infection by species of Eimeria that are 
not included in the vaccine (Augustin 1996).  Therefore, this action must be accounted 
for in vaccine development. 
Live Oocyst Vaccination  
The worldwide poultry industry provides a substantial proportion of the 
nutritional needs of the human population.  To keep pace with the increasing demand for 
the high-quality, low cost protein source that poultry represents, intensive rearing 
practices have been developed in the past few decades (Lillehoj et al., 2000).  A major 
consequence of these practices has been an increase in the incidence of diseases, 
including coccidiosis.  Coccidiosis has historically been controlled with the inclusion of 
a number of different dietary coccidiostats.  Medication via the feed has proved to be 
convenient, efficient in terms of labor, and as such cost effective, thus enabling large 
numbers of chickens to be reared in intensive conditions of the modern poultry industry 
(Chapman, 1993).  Most coccidiostats inhibit asexual stages of the life cycle of Eimeria.  
Ionophorous antibiotics including monensin, salinomycin, narasin, lasalocid and 
maduramicin are currently the most widely used drugs for the control of coccidiosis.  
The mechanisms of action is their capability of transporting cations through biological 
membranes affecting a diverse range of cellular processes dependent upon ion transport 
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(Chapman, 1993).  Diclazuril, the latest coccidiostat to become available, has been 
shown to be highly effective at improving performance parameters of broilers raised on 
litter contaminated with Eimeria spp. (Conway et al., 2002a).  However, its use does not 
allow for the generation of immunity to Eimeria tenella (Conway et al., 2002b).  
Monensin has been shown to affect the ultrastructure of Eimeria spp. evidenced by 
vacuoles in the cytoplasm, separation of plasma membrane layers, and dense bands in 
the refractile bodies reducing the ability of cellular invasion of the parasite (Augustine et 
al., 1992).  Use of monensin resulted in improved growth during E. acervulina infection 
(Willis and Baker, 1981a).  Even though these drugs remain effective now, resistance 
has begun to arise to all them (Chapman, 1993). 
Infections with coccidia parasites have been calculated to cost the US poultry 
industry in between $450 million and $1.5 billion (Yun et al., 2000) annually.  
Approximately 80% of the cost is due to losses in feed conversion and weight gain even 
in the presence of drug treatment strategies (Vermeulen et al., 2001).  Decreased 
performance characteristics indicate the decreased effectiveness of anticoccidials 
indicating a need for new strategic concepts to control coccidiosis (Williams et al., 1999; 
Vermeulen et al., 2001; Allen and Fetterer, 2002a; Chapman et al., 2002; Williams, 
2002).   
 Live oocyst vaccines are currently the only commercially available option for the 
control of coccidiosis in the poultry industry other than anticoccidial feed additives 
(Williams, 1998).  Live oocyst vaccines are comprised of either virulent Eimeria species 
(Ex. Coccivac® and Immucox®) or attenuated Eimeria species (Ex. Paracox® and 
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Livacox®).  Coccidia may be attenuated in any of three ways presently known: by 
passaging through embryonating chicken eggs, gamma irradiation, or selection for 
precocity (Williams, 1998).  Passaging through eggs is possible for only a few Eimeria 
species.  This type of attenuation may be associated with loss of immunogenicity of the 
line, and may not produce a stable attenuation (Shirley, 1993). The irradiation method is 
unlikely to lead to a commercial vaccine since the attenuation seems to depend to some 
extent simply on killing oocysts.  This method has not been shown to be stable (Shirley, 
1993).  The best method of attenuation is by selection for precocity (Jeffers, 1975).  The 
essential characteristics are decreased prepatent time or a reduced reproductive potential 
resulting in attenuation of virulence, maintenance of immunogenicity, and genetically 
control stability (William, 1998).  All live vaccines are currently recommended for 
administration when chicks are quite young.  Even though vaccines are given at a young 
age, in some circumstances, heavy wild-type oocyst contamination of a poultry house 
might produce clinical disease before a vaccine has established protective immunity 
(Williams, 1998).   
There are several factors to take into consideration when evaluating anticoccidial 
vaccination.  These factors include species inclusion, immunogenic variation in strains 
of Eimeria species, and the development of immunity in chickens as a result of the 
vaccine (Williams, 2002).  All species that are likely to be encountered in commercial 
production of broilers should be included in any vaccine.  Currently, E. acervulina, E. 
maxima, and E. tenella are included in all commercially available live oocyst vaccines.  
If a species is present in a particular rearing environment and not included in a vaccine, 
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that species may be able to cause disease in certain circumstances (Williams, 2002).  
Immunogenic variation is another aspect that is of concern with the implementation of 
anticoccidial vaccination.  Incomplete protection due to immuno-variability between 
coccidial species present in the vaccine and those found in poultry rearing facilities has 
emerged as a potential complicating factor associated with vaccination (Martin et al., 
1997; Caldwell et al., 2004).  
Williams (1998) states that an advantage to the use of attenuated vaccines is that 
local virulent strains challenge the birds and fresh oocysts accumulate in the litter.  
Genetic recombination between vaccinal and wild coccidia would be expected to 
increase, and that this series of events with the reintroduction of attenuated oocysts with 
each new vaccination doubtlessly produces oocysts heterozygous for precocity 
(Williams, 1998).  This recombination possibly reduces the pathogenicity of the resident 
coccidial population.  The use of Coccivac® in poultry houses where drug-resistant 
parasites are problematic, increases the sensitivity of the resident coccidial population 
after several flocks have been vaccinated (Chapman, 1994).  Due to genetic 
recombination, residual oocysts carried over to each successive flock are likely to 
become more drug-sensitive and perhaps less virulent during each vaccination cycle 
(Williams, 1998; Chapman et al., 2002).  While several vaccines, both attenuated and 
non-attenuated, have been used to treat broiler breeders, there has been a general 
reluctance to use them in broilers and heavy roaster birds because of reports of reduced 
weight gain and increased feed conversion ratios compared to prophylactically 
medicated birds (Allen and Fetterer, 2002a).  Several published reports have evaluated 
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the use of live oocyst vaccination for control for coccidiosis in broilers and are 
summarized below. 
 Williams (1994) investigated the safety of the use of an attenuated vaccine 
(Paracox®) on broiler performance.  Vaccination was compared to a commonly used 
anticoccidial feed additive, nicarbazin.  Broilers were housed in an environment free of 
extraneous virulent coccidial species.  Oocysts were not present in medicated broilers at 
anytime within the experiment indicating that no extraneous Eimeria were present and 
that cross contamination by the vaccine strain did not occur.  At the conclusion of the 
growout period (d 54), vaccinated broilers performed better than medicated broilers with 
a 10.4% increase in body weight, 7.2% reduction in feed conversion, and 44.4% 
reduction in mortality.  Broilers were sampled throughout the experiment for the 
detection of lesions associated with vaccination.  Lesions were only present in a small 
percentage of vaccinated broilers (4%).  Recycling of the attenuated coccidia occurred in 
vaccinated broilers with oocysts present in the litter between 5 and 33 d after vaccination 
with a single peak between 5 and 12 d after vaccination.  Williams (1994) concluded that 
these results reflect the safety of the Paracox® vaccine. 
 Danforth et al. (1997a) evaluated the generation of protective immunity in three 
different strains of male and female chickens immunized at 1 day of age with a drug-
resistant field isolate of E. maxima in both battery and floor pen trials.  The generation of 
immunity due to immunization with 2500 oocysts/bird was evidenced by reduced lesion 
development and increased weight gain in all three strains of chickens.  In the floor pen 
trial, there was no interference of immunity generation with inclusion of three different 
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anticoccidial shuttle programs including narasin, nicarbazin, or monensin.  Broilers were 
determined to be immunized upon E. maxima challenge based on lesion development 
and weight gains.  There were no differences in performance parameters between any of 
the three different shuttle programs utilized by Danforth et al. (1997a).   
 If live oocyst vaccination was to be adopted by the commercial broiler industry, a 
route of administration that allows for a uniform distribution of the vaccine to all chicks 
needed to be identified.  Danforth et al. (1997b) investigated several delivery techniques 
of the Immucox® vaccine which included gavage, spray cabinet, conventional Vetech 
delivery system, or gel-delivery system.  A series of experiments conducted to evaluate 
these delivery systems indicated that the gel-delivery system with Immucox® vaccine 
improved uniformity of the primary vaccination infection.  The gel-delivery system 
elicited an overall enhanced protective immune response in roaster birds compared to the 
other delivery systems (Danforth et al., 1997b).  Vaccinated broilers (Immucox plus 500 
oocysts of a local field strain of E.maxima) via gel-delivery and reared on litter seeded 
with a local strain of E. maxima had similar growth characteristics at d 70 to medicated 
broilers (Maxiban/Monteban shuttle program) raised on similar litter.   However, the 
average gain to d 35 was significantly lower in the vaccinated group compared to the 
medicated group.  The results of this series of experiments indicated that the other 
immunization techniques showed protective immune responses during a challenge 
infection, but the gel-delivery system was the only vaccinated group that yielded body 
weight gains similar to non-immunized controls.   
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 The generation of immunity with live oocyst vaccination as a result of protection 
against an Eimeria challenge was further investigated and reviewed by Danforth (1998).  
Immunization of male and female chickens with 2500 oocyst/bird E. maxima at 1 d of 
age allowed for protection upon subsequent challenge with 25000 oocysts at d 10.  
Vaccinated broilers had significantly increased weight gains and lower lesion scores 7 d 
post-challenge compared to non-immunized chickens although vaccination led to a 
check in body weight gain pre-challenge.   
Live oocyst vaccines must be comprised of Eimeria species strains which are in a 
particular geographic region due to lack of cross-protection observed between different 
strains of the same Eimeria species (Danforth, 1998).  This observation was observed by 
Danforth et al. (1997b) when using Immucox.  The E. maxima strain present in the 
vaccine would not elicit protection against the field strain E. maxima present in 
Maryland.  Thus a modification had to be made to the vaccine with the addition of 500 
oocyst of the Maryland field strain to the vaccine in order to generate efficient immunity 
upon field strain challenge.  This represents an extremely important aspect that must be 
considered when adopting a live oocyst vaccination program. 
 Waldenstedt et al. (1999a) evaluated the used of a live attenuated anticoccidial 
vaccine (Paracox®) compared with an anticoccidial ionophore (Narasin) during a 36 d 
grow out of broilers isolated from extraneous Eimeria parasites.  At the conclusion of the 
study, vaccinated broilers were lighter in terms of body weight (4.6%) and had a higher 
feed conversion ratio (2.5%) compared to unvaccinated medicated broilers.  This 
reduction in performance could not be avoided with the inclusion of virginiamycin into 
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the diet of vaccinated broilers.  One other observation made by Waldenstedt et al. 
(1999a) was that throughout the experiment cecal clostridial counts were considerably 
higher in vaccinated unmedicated broilers than in unvaccinated birds given narasin.   
 Williams et al. (1999) investigated the use of an attenuated anticoccidial vaccine 
compared to anticoccidial drug shuttle programs in a large field trial.  Virginiamycin was 
included in all diets.  The parameters evaluated included feeding cost, feed conversion, 
mortality, coefficient of variation of body weight, culled birds, total water consumption, 
and birds rejected during processing.  No significant differences were observed in any of 
the parameters evaluated except feed conversion and mortality.  Vaccination of broilers 
yielded a significantly higher feed conversion ratio although no difference was observed 
in feeding cost.  Significantly lower mortality was observed in the vaccinated broilers 
compared to the medicated shuttle programs.  This difference was probably observed 
due to two necrotic enteritis outbreaks that were observed in medicated broilers while 
necrotic enteritis was not observed in vaccinated broilers.  One of these outbreaks was 
associated with a coccidiosis infection.  The investigators concluded that there must be 
some ionophore and virginiamycin resistant Eimeria and Clostridium prefringens 
present in the affected houses.  The final mean weights of the birds, often used as a 
major criterion in commercial poultry trials, were of no relevance in this experiment 
because the feed consumption of the birds was controlled in an attempt to achieve even, 
predetermined weights throughout the trials (Williams et al., 1999). 
Williams and Gobbi (2002) conducted another field trial evaluating the use of the 
vaccine Paracox® when directly compared to a medication shuttle program.  The 
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medication shuttle program consisted of nicarbazin in the starter diets and monensin in 
the grower and finisher diets.  Females were reared to 36 d of age and males to 56 d of 
age.  At the conclusion of three flocks, vaccinated broilers were significantly heavier 
than medicated broilers.  This difference was observed at d 27 and persisted through the 
remainder of grow out for males and females.  Vaccinated broilers also had lower feed 
conversion ratios by 2 and 3 points for females and males, respectively.  As well, 
significantly fewer vaccinated males were rejected at processing compared to medicated 
broilers.  Williams and Gobbi (2002) concluded that anticoccidial vaccination of broilers 
with Paracox® may afford performance equal to that obtained with a traditional 
anticoccidial drug shuttle program. 
Williams (2003) evaluated the ability of Paracox®, an attenuated vaccine, to 
generate immunity in broilers judged by lesion development and body weight gain.  
Upon challenge with several species individually, vaccinated broilers had decreased 
lesion development and increased weight gain compared to naïve control broilers.  
Vaccinated broilers had lower coefficients of variation with respect to weight gain 
compared to naïve control broilers.  Upon microscopic evaluation of the lesions in 
challenge broilers, all intestinal smears from naïve chickens contained merozoites, 
gametocytes, or oocysts.  Intestinal smears from vaccinated broilers containing intestinal 
lesions indicated that the majority of the lesion (68%) exhibited no parasites with the 
remaining intestinal smears (32%) containing very few parasites.  Williams (2003) 
concluded that fully immune birds may exhibit gross lesions with few or no endogenous 
parasites after virulent challenges suggesting that the paucity of parasites in lesions 
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occurring in immune birds is due to an immune response of the host rather than to the 
genetically controlled reduced fecundity of an attenuated challenge organism. 
Further investigation by Crouch et al. (2003) of the attenuated vaccine, 
Paracox®-5, validated the findings of Williams (2003).  Broilers were vaccinated on 1 d 
of age and challenged with an individual species on 28 d of age with one of the 
following species: E. acervulina, E. maxima, E. mitis, or E. tenella.  Performance was 
improved with vaccination compared to non-vaccination 7 d post-challenge evidenced 
by increased body weight gains and reduced feed conversion.  Lesion scores were also 
significantly lower in vaccinated broilers compared to non-vaccinated broilers.  Lesions 
were not present in the majority of vaccinated broilers while all non-vaccinated broilers 
exhibited lesions with the majority having lesion scores of 3 or 4.  In a second study, 
seeder birds were added to pens of either vaccinated or non-vaccinated broilers at 14 d of 
age.  Vaccinated broilers had significantly increased body weight gains and lower feed 
conversion ratios.  Vaccinated broilers were similar to the negative control broilers in 
which seeder birds were not added.  These data demonstrate the protective efficacy of a 
live coccidiosis vaccine (Paracox-5) based on precocious lines of E. acervulina, E. 
maxima, E. mitis, and E. tenella, administered to 1 d old chicks against all constitutive 
vaccinal species (Crouch et al. 2003). 
An attenuated vaccine developed by Li et al. (2004) containing E. acervulina, E. 
maxima, and E. tenella which were resistant to monensin was evaluated to determine the 
performance characteristics of chickens vaccinated with ionophore tolerant oocysts (Li 
et al., 2005).  Chickens were vaccinated at 3 d of age by gavage or drinking water with a 
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virulent Eimeria challenge 3 weeks post-vaccination.  Vaccination with gavage required 
a lower dose as compared to the drinking water in order to generate appropriate levels of 
immunity.  Chickens vaccinated with the ionophore tolerant vaccine with either method 
and fed a medicated diet (monensin) had significantly higher final body weights 4 weeks 
post-infection as compared to medicated and vaccinated chickens.  A vaccine containing 
ionophore resistant Eimeria proved to be efficacious and provided satisfactory protection 
and in combination with the use of ionophores and could be a useful adjunct to planned 
immunization in the control of coccidiosis (Li et al., 2005). 
Recently, the effects of vaccination with an attenuated vaccine on the intestinal 
microbial ecology of broilers were investigated.  Oviedo-Rondon et al. (2006) compared 
the microbial ecology of both vaccinated and non-vaccinated broilers fed diets 
supplemented with essential oils.  Their results indicate that vaccination by itself causes 
small changes on intestinal microbial communities and that coccidia infection results in 
drastic shifts in microbial communities.  Inclusion of the essential oils modulated 
microbial communities during coccidial challenges and avoided drastic changes in these 
communities after coccidia infection independent of vaccination. 
Possible vaccines for the control of coccidiosis have been evaluated on several 
criteria including lesion development and oocyst shedding.  These criteria while 
acceptable for the evaluation of drug efficacy in chickens are not completely appropriate 
for the determination of vaccine efficacy (Williams and Catchpole, 2000).  Many times 
chickens that are immune to Eimeria species may produce mild lesions and have small 
amount of oocysts shedding but will have no check in body weight gain or feed 
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conversion ratio.  Williams and Catchpole (2000) developed a protocol for the 
evaluation of possible anticoccidial vaccines.  The judgment of immunity development 
was based on feed conversion and body weight gain of vaccinated birds following a 
subsequent challenge of an Eimeria species present in the vaccine.  The benefits of the 
protocol over previous ad hoc experimental designs are: 1. immunization is carried out 
with multivalent vaccines of Eimeria species up to the maximum of seven that may 
infect chickens; 2. assessments of immunity are carried out for each species separately 
so results can not be confounded; 3. the criteria of efficacy are those that are crucial to 
demonstrate commercial usefulness; 4. the possibility of drawing erroneous conclusions 
based upon inappropriate criteria such as oocyst production or lesion scores is avoided; 
5. because the same criteria are used for each species, direct comparisons may be made 
amongst immunities to all of the species in the vaccine being tested (Williams and 
Catchpole, 2000).  While this protocol is useful in determining the efficacy of a vaccine 
to produce immunity, the application in the field for this type of protocol is impossible 
because poultry houses more likely than not contain multiple species of Eimeria. 
Allen et al. (2004) also development a protocol to measure the effectiveness of 
anticoccidial vaccination in the generation of immunity in broilers and subsequent 
protection against a field strain challenge to one of three different strains of E. maxima.  
The calculation of the protective index included four independent measurements.  The 
measurements included weight gain and lesion score which are two important 
parameters used to measure the effectiveness of a treatment such as vaccination to 
control coccidiosis.  The two other factors used to calculate the protective index were 
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plasma carotenoids and plasma NO2- + NO3-.  Decreases in plasma carotenoids are 
recognized as sensitive indicators of coccidiosis-associated pathology in the small 
intestine (Allen, 1992) and plasma NO2- + NO3- concentrations have been found to 
increase during primary infection in a dose related manner (Allen, 1997).  These values 
when taken at 6 d post-infection tend to be significantly correlated. The protective index 
(PX) is calculated for each chicken using the following algorithm: PX = (Ngain + 
Ncarotenoids) – (Nsquare root lesion score + N[NO2- + NO3-]) (Allen et al., 2004).  Mean PX values of 
unchallenged groups cluster around 0 with mean PX values of protected chickens 
statistically similar to those from unchallenged groups and unprotected chickens have a 
mean PX value highly negative compared to the other groups (Allen et al., 2004).  This 
protocol allows for the evaluation of different strains of Eimeria for the possible 
inclusion in anticoccidial vaccines allowing for the measurement of cross protection 
across strains.  This protocol can also be used to rank the effectiveness of different 
anticoccidial treatments. 
The use of anticoccidial vaccines has been investigated and while their 
effectiveness at generating immunity is not questioned, there is debate within the 
literature of the expected performance of vaccinated broilers compared to anticoccidials.  
Some researchers have observed reduced growth characteristics evidenced by decreased 
weight gain (Danforth et al., 1997b; Danforth, 1998; Waldenstedt et al., 1999a; 
Williams, 2002) and increased feed conversion ratios (Williams et al., 1999; 
Waldenstedt et al., 1999a) while other reports indicate that vaccinated broilers perform 
equally or better than medicated broilers (Danforth, 1998; Williams and Gobbi, 2002).   
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Dietary Modulation for Improved Performance during Coccidiosis 
 The effects of coccidiosis on nutrient absorption, body weight gain, and feed 
conversion have been well document.  Research has focused on dietary modulation 
during periods of coccidiosis for the improved performance of broilers during infection 
(Allen et al., 1998).  Fat absorption has been shown to decrease during E. acervulina 
infection (Sharma and Fernando, 1975).  The addition of 0.4 g/kg of cholic acid can 
significantly improve fat digestion during an E. acervulina infection although no effect 
on performance parameters was observed (Adams et al., 1996b).  Substitution of animal 
fat in the diet with coconut oil, which has a high concentration of medium-chain 
triacylglycerols, improved fat digestion during E. acervulina infection and consequently 
led to increased body weight gain and a reduced feed conversion (Adams et al., 1996b).  
The reasons for these improvements in fat digestion are related to the characterization of 
the lipid.  Medium-chain triacylglycerols have greater water solubility, enter enterocytes 
without hydrolysis as a result of their smaller molecular size, and present a greater 
surface for lipase enzyme action, and short chain length results in more efficient 
absorption by the diseased mucosal surface (Babayan, 1987).    
 The search for new methods of control of coccidiosis in chickens has led to 
investigations of possible compounds with anticoccidial properties.  Inclusion of 
Artemisia annua (annual wormwood) leaves at a dietary level of 5% protected chickens 
from E. tenella infection with reduced lesion development, and 1% inclusion indicated a 
possible protection against post-vaccine reductions in body weight and feed efficiency 
(Allen et al., 1997).  Artemisia annua has been noted for its anti-malaria properties and 
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its use to treat human malaria.  While this inclusion level is probably not realistic, 
isolation of the active compounds and addition of these compounds into the diet at 
significantly lower concentrations may in fact be realistic.  The inclusion of artemisinin 
(17 ppm), camphor (119 ppm), and 1,8-cineole (119 ppm) significantly increased weight 
gain and reduced lesion scores of chickens during a mixed species challenge of E. 
acervulina and E. tenella (Allen et al., 1997).   
 In the past decade, considerable research has focused on the effects of betaine 
(trimethyl glycine) on chicken performance with and without anticoccidial feed additives 
during coccidial challenge.  It has been used to replace a portion of the sulfur amino acid 
requirement (Pesti et al., 1979) as well as being an osmoprotectant to allow cells to 
tolerate osmotic stress (Bagnasco et al., 1986).   Matthews et al. (1997) investigated the 
addition of betaine in broilers diets in combination with monensin and Eimeria 
challenge.  The addition of 0.1% betaine significantly increased weight gain and feed 
intake of E. acervulina infected chickens and the addition of 0.5% betaine led to 
improved feed efficiency.  The addition of 0.1% of betaine in combination with 
monensin (55 ppm) significantly improved feed efficiency, and the addition of betaine 
tended to increase feed efficiency of uninfected chickens.  When the level of monensin 
was increased to 110 ppm, feed efficiency of uninfected chickens increased while 
decreasing feed efficiency in uninfected chickens when used without monensin.  Betaine 
may have an effect on E. acervulina-infected chickens but no conclusive evidence 
indicates an improvement of monensin efficacy when fed in combination with betaine 
(Matthews et al., 1997).   
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Betaine has been shown to have beneficial effects when fed in combination with 
salinomycin (Augustine et al., 1997).  Addition of betaine at 0.15% in combination with 
salinomycin at 66 ppm resulted in improved performance characteristics than either fed 
alone. Reduced invasion by E. acervulina and E. tenella as compared with untreated 
controls was also observed.  This enhanced effect observed with betaine in combination 
with the ionophore, salinomycin, was not observed when betaine was used in 
combination with another commonly used ionphore, narasin (Waldenstedt et al., 1999b).  
Inclusion of betaine alone led to increased live weight of broilers but no positive effect 
in combination with narasin was observed.   
Matthews and Southern (2000) observed inconsistent results with respect to 
dietary betaine inclusion (0.075%).  In two experiments consisting of an acute and 
chronic infection with E. acervulina, betaine inclusion had no effect on performance 
parameters in the initial experiment while broilers fed betaine exhibited increased weight 
gain, feed efficiency, and lesion development in the replicate experiment.  Betaine fed 
alone did not consistently affect growth performance in chronic or acute coccidiosis-
infected chicks (Matthews and Southern, 2000).   
Betaine supplementation has been shown to positively influence plasma betaine 
concentrations which were significantly decreased during an E. maxima infection 
(Fetterer et al., 2003).  The increased levels of betaine resulted in consistently higher 
chick weights than control chicks and were significantly increased during E. maxima 
challenge.  Klasing et al. (2002) investigated the effects of dietary betaine on 
performance parameters, intestinal osmolarity, number of leukocytes, villus height, and 
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immune cell function during an E. acervulina infection.  Inclusion of betaine decreased 
osmolarity of the duodenum which was increased with coccidial infection and increased 
the numbers of intraepithelial leukocytes.  Coccidial challenge resulted in decreased 
villus height but this was ameliorated with the inclusion of 1.0g/kg of dietary betaine.  
Betaine inclusion increased nitric oxide release by peripheral blood heterophils and 
peritoneal macrophages and increased the release of chemotactic factors from 
heterophils.  Klasing et al. (2002) demonstrated that at least part of the protective effect 
of betaine can be attributed to enhancement of monocyte chemotaxis and nitric oxide 
production by heterophils and macrophages.   
N-3 fatty acids have been observed to reduce lesion development (Allen et al., 
1996) and increase weight gain in broilers (Allen et al., 1996; Korver et al., 1997) fed 
increased dietary concentration of n-3 fatty acids following an E. tenella infection.  
Further studies orchestrated by Danforth et al. (1997c) indicated that E. tenella 
development in chickens fed high n-3 fatty acid diets showed ultrastructural 
degeneration of asexual and sexual parasite stages and the early release and shedding of 
asexual and sexual parasite developmental stages into the cecal lumen.  Ultrastructural 
degeneration was characterized by cytoplasmic vacuolization, chromatin condensation 
within the nucleus, a lack of parasitophorous vacuole delineation, and in some cases 
complete loss of parasite ultrastructural organization (Danforth et al., 1997c).  Allen et 
al. (1996) speculate that when fed to birds beginning at 1 d of age, diets high in n-3 fatty 
acids would cause oxidative destruction of the parasite.  Persia et al. (2006) also 
observed beneficial effects of the addition of 10% fish meal, which is high in n-3 fatty 
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acids, in chicken diets resulting in improved performance of chicks during E. acervulina 
infection.  These authors also investigated the use of a prebiotic-type product, which 
contains dairy and yeast fractions and dried fermentation extracts, on performance.  
Improved performance was observed in the absence of coccidial challenge but no 
beneficial effects were observed in chickens challenged with E. acervulina.   
Vitamin E has shown to function as an antioxidant and immunomodulator in 
chickens (Boa-Amponsem et al., 2000), but Allen and Fetterer (2002b) determined that 
vitamin E supplementation did not alleviate the negative effects on broiler performance 
and development of mucosal lesions associated with E. maxima challenge.  The authors 
base this ineffectiveness of feeding a fat-soluble form of vitamin E is that it is 
malabsorbed during E. maxima infection and becomes less biologically available to 
infected tissues during an acute infection.   
Vitamin A deficiency in broiler diets results in decreased numbers of 
intraepithelial lymphocytes expressing CD3, CD4, and CD8 surface markers and 
resulted in more surface Ig-A expressing cells than non-deficient controls (Dalloul et al., 
2002).  Upon introduction of challenge with E. acervulina, vitamin A deficient broilers 
showed lower CD4 expressing cells and increased oocyst shedding compared to non-
deficient broilers.  An increase in CD8 cells was not observed in vitamin A deficient 
broilers but was observed in non-deficient broilers (Dalloul et al., 2002).  These authors 
concluded that vitamin A deficiency compromises local immune defenses of challenge 
broilers, as reflected in lymphocyte profiles and oocyst shedding. 
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In conclusion, considerable research has focused on dietary modulation in an 
effort to improve broiler performance during periods of clinical coccidiosis, mainly 
focusing on micronutrients and neglecting the effects of dietary protein levels.  Dietary 
supplementation with micronutrients is confounded by the negative effect on intestinal 
absorption caused by all of the coccidia species (Allen and Fetterer, 2002b).  In addition, 
the anorexia associated with coccidial infection can result in decreased feed intake and 
may also affect the intestinal levels of betaine and other micronutrients (Allen and 
Fetterer, 2002a).  Dietary modulation aimed at improved broiler performance during 
periods of coccidiosis focused on protein level specifically is unclear.   
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CHAPTER III 
THE EFFECT OF PROTEIN LEVEL ON GROWTH PERFORMANCE OF LIVE 
OOCYST VACCINATED BROILERS FOLLOWING A SUBSEQUENT MIXED 
SPECIES EIMERIA CHALLENGE 
Introduction 
 Coccidiosis is an intestinal disease of intensively reared livestock cause by 
coccidial parasites of the genus Eimeria.  The disease causes intestinal epithelium 
lesions, reduction of body weight, reduced feed efficiency, and often overt morbidity and 
mortality (Guzman et al., 2003).  Economically, the most important members of Eimeria 
which infect chickens worldwide are E. acervulina, E. brunette, E. maxima, E. mitis, E. 
praecox, E. necatrix, and E. tenella (Shirley et al., 2005).  Infections with E. acervulina, 
E. maxima, and E. tenella are diagnosed frequently in intensively reared poultry 
(McDougald et al., 1997).  It has been estimated that coccidiosis costs the world’s 
commercial chicken producers at least $800 million each year (Williams, 1998) with 
approximately 80% of this cost due to poor performance (Williams, 1999). As the 
world’s poultry production continues to grow so do the concerns about the control of 
coccidiosis, since commercial chicken flocks found to be free from coccidia are 
extremely rare (Williams, 2002).  Historically, the poultry industry has relied on 
anticoccidial drugs for the control of coccidiosis but resistance of coccidia has developed 
to all of the anticoccidial drugs introduced so far (Chapman, 1997). Consumers are 
becoming increasingly concerned about drug residues in poultry products (McEvoy, 
2001), resulting in increased pressure from a percentage of consumers to remove drugs 
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from animal feeds.  For these reasons, there is a pressing need to move away from 
chemotherapeutic control of coccidiosis in favor of non-medicated forms of control such 
as vaccination (Williams, 2002).    
 Vaccination against coccidiosis is not a new concept and has been used in the 
poultry industry for around 50 years (Shirley et al., 2005).  Live oocyst vaccination using 
attenuated and non-attenuated Eimeria is currently the only commercially available 
vaccination strategy for control of coccidiosis in poultry.  These vaccines provide solid 
immunity to coccidial infection when applied carefully under good rearing conditions 
(Shirley and Long, 1990).  Despite their proven success in eliciting effective protection 
against coccidiosis in replacement and breeding flocks, these vaccines have not been 
universally accepted by the U.S. poultry industry for meat producing broiler and heavy 
roaster bird flocks (Danforth, 1998).  The reluctance of broiler producers to adopt 
anticoccidial vaccination strategies is related to several reports on measured performance 
parameters associated with vaccination, weight gain and feed efficiency.  Performance of 
vaccinated broilers has not always equaled that of medicated broilers (Danforth, 1998; 
Williams, 2002).  The reduced performance is related to mild coccidia infection 
associated with live oocyst vaccination.  Increasing protein level during periods of 
clinical coccidiosis has been shown to improve broiler performance (Sharma et al., 
1973) but such a strategy to date has not been evaluated during live oocyst vaccination.  
The objective of the current research was the evaluation of dietary protein level on 
broiler performance and lesion development during live oocyst vaccination with 
Coccivac®-B and subsequent mixed species Eimeria challenge. 
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Materials and Methods 
 A series of four experiments were designed to evaluate the effect of selected 
levels of dietary protein on broiler performance and immunity generation while utilizing 
a vaccination program for the prevention of coccidiosis.  Growth parameters of 
vaccinated broilers were compared to non-medicated non-vaccinated broilers prior to 
and following a mixed species Eimeria challenge. For each of the following 
experiments, broiler chicks were provided age appropriate supplemental heat and given 
access to feed and water ad libitum.  All animal care procedures were conducted in 
accordance with an Animal Use Protocol approved by the Texas A&M University 
laboratory animal care committee.  Prior to chick placement, grow out facilities were 
thoroughly cleaned and disinfected.  Fresh pine shavings were used for bedding material.  
Pens were equipped with one 30 lb tube feeder and nipple drinkers.  In experiments that 
included a mixed species Eimeria challenge, dose titration of the challenge inoculum 
was performed prior to experiment to identify a dose sufficient to cause identifiable 
gross lesions in vaccinated broilers. 
Experiment 1 
Experiment 1 was a randomized block design consisting of 5 dietary protein 
levels (20, 21, 22, 23, and 24%) with eight replicates of each protein level for a total of 
40 pens.  Each replicate contained 25 chicks for a total of 1000 chicks placed.  During 
diet formulation, diets were formulated on an isocaloric basis and careful consideration 
was given to maintain constant amino acid to protein ratios throughout all 5 dietary 
treatments (Table 3-1).  The 23% dietary treatment met or exceeded NRC (1994)  
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Table 3-1.  Calculated nutrient concentrations of experimental diets used in Experiments 
1 through 4. 
 
Nutrient 
Protein (%)           20.0           21.0           22.0           23.0           24.0 
Methionine  0.44  0.47  0.50  0.52  0.55 
TSAA   0.78  0.82  0.86  0.90  0.94 
Lysine   1.06  1.12  1.19  1.26  1.33 
Threonine  0.75  0.79  0.83  0.87  0.91 
Arginine  1.32  1.40  1.48  1.55  1.63 
Tryptophan  0.24  0.25  0.27  0.28  0.30 
Calcium  0.90  0.90  0.90  0.90  0.90 
Available Phos. 0.45  0.45  0.45  0.45  0.45 
Sodium  0.20  0.20  0.20  0.20  0.20 
ME (kcal/kg)       3200       3200       3200       3200       3200 
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specifications for a broiler starter diet.  On day of hatch, all chicks were individually 
weighed (top and bottom 5% discarded), wing banded and vaccinated with Coccivac®-B 
by oral gavage.  Once vaccinated, chicks were randomly assigned to treatment groups 
using chick weight.  Broiler chicks were fed dietary treatment for 21 d at which time pen 
weights were taken and feed consumption determined for the calculation of feed 
conversion ratios.   
Experiment 2 
The experimental design utilized for Experiment 2 was a 3 x 2 x 2 factorial 
designed to determine the effect of one of three dietary protein levels (20, 22, and 24%), 
vaccination (vaccination compared to non-medicated non-vaccination), and mixed 
species Eimeria challenge (21 d of age) on broiler chick performance.  This 
experimental design generated a total of 12 treatment groups and each group was 
replicated in triplicate.  Each replicate contained 25 chicks for a total of 900 chicks 
placed.  Dietary treatments were identical to those utilized in Experiment 1 for the three 
protein levels selected (Table 3-1).  On day of hatch, chicks were individually weighed 
(top and bottom 5% discarded), wing banded, and assigned to treatment groups.  Chicks 
assigned to vaccinated treatment groups were vaccinated using Coccivac®-B in a 
commercial spray cabinet that vaccinates 100 bird chick trays.  A red food coloring dye 
was added to the vaccine and chicks were allowed to preen for 1 hr before placement to 
allow for vaccine uptake. On d 21, pen weights were taken and feed consumption 
determined for the calculation of feed conversion ratios.  Half of the treatment groups 
were challenged with a mixed species challenge containing Eimeria acervulina (6 x 105), 
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Eimeria maxima (4 x 105), and Eimeria tenella (2 x 105) sporulated oocysts.  On d 27 (6 
days post-challenge), pen weights were taken, feed consumption determined, and 10 
broilers from each replicate necropsied for the quantitative assessment (scoring) of 
intestinal lesion development (Johnson and Reid, 1970).   
Experiment 3 
The experimental design for Experiment 3 was a replicate of Experiment 2 with 
some slight alterations.  All treatment groups remained the same although replicate 
number was decreased from three to two, increased bird number per replicate from 25 to 
30, and increased the number of birds necropsied per replicate from 10 to 15.  On day of 
hatch, chicks were weighed, wing banded, and assigned to treatment group based on 
chick weight.  Chicks were vaccinated in a commercial spray cabinet for 100 bird chick 
trays.  A red food coloring dye was added to the vaccine and chicks were allowed to 
preen for 1 hr before placement to allow for vaccine uptake. On d 20, pen weights were 
taken, feed consumption determined, and chicks were challenged with a mixed species 
challenge consisting of Eimeria acervulina (6 x 105), Eimeria maxima (4 x 105), and 
Eimeria tenella (2 x 105) oocysts.  On d 26 (6 days post-challenge), pen weights were 
taken, feed consumption determined, and 15 broilers from each replicate necropsied for 
the determination of intestinal lesion development (Johnson and Reid, 1970).   
Experiment 4  
 With the results of the previous three experiments, Experiment 4 investigated the 
effect of starter diet duration on broiler chick performance during an anti-coccidial 
vaccination program with subsequent Eimeria challenge.  The experimental design was a 
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3 x 2 x 2 factorial with the variables of starter period duration (13, 17, and 21 d), 
vaccination (vaccinated compared to non-medicated non-vaccinated), and a mixed 
species Eimeria challenge (challenge and non-challenged).  Each treatment was 
replicated in triplicate for a total of 36 pens.  Each replicate contained 25 chicks placed 
for a total of 900 chicks placed.  Again, chicks were individually weighed, wing banded, 
and assigned to treatment groups by weight.  A red food coloring dye was added to the 
vaccine and chicks were allowed to preen for 1 hr before placement to allow for vaccine 
uptake. Pen weights and feed consumption were determined on days 13, 17, 21, and 27.  
The 22% starter diet used in the previous three experiments was fed to broilers for either 
13, 17, or 21 days depending on treatment.  At the conclusion of the starter period, 
rations were switched to a grower diet formulated to meet the specifications of the high 
nutrient density diet specified in Leeson and Summers (2005) with the exception of the 
energy value being maintained at 3200 kcal/kg.  On d 21, broilers were challenged with 
a mixed species challenge consisting of Eimeria acervulina (1.25 x 106), Eimeria 
maxima (4 x 105), and Eimeria tenella (5 x 104) sporulated oocysts.  On d 27 (6 days 
post-challenge), pen weights were taken, feed consumption determined, and 10 broilers 
from each replicate pen were necropsied for the determination of intestinal lesion 
development (Johnson and Reid, 1970).   
Statistical Analysis 
Experiment 1 
Data were analyzed using SPSS Version 11.0 for Windows (SYSTAT, 2001) for 
all experiments.  Statistical significance was determined by one-way analysis of variance 
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and means were separated by Duncan’s multiple range test.  The threshold for statistical 
significance was P < 0.05. 
Experiment 2 
 Body weights and feed conversion ratios for d 21 data were analyzed using a 
one-way analysis of variance due to the presence of a significant interaction between 
protein level and vaccination.  Significant differences were determined at P < 0.05 and 
means were separated using a Duncan’s Multiple Range Test.  Similarly, due to an 
interaction between challenge and vaccine, data collected on d 27 including post-
challenge body weight gain, feed conversion ratios, mortality, and lesion scores were 
analyzed using a one-way analysis of variance with differences deemed significant at P < 
0.05.  Means were separated using a Duncan’s Multiple Range Test.  Post-challenge 
mortality was subjected to a square root arc sin transformation before analysis. 
Experiment 3 
Body weight and feed conversion ratios for d 20 were analyzed using a 3 x 2 
factorial analysis of variance.  No significant interaction was observed as in Experiment 
2.  Post-challenge body weight gains, feed conversion ratios, and lesion scores were 
analyzed using a one-way analysis of variance because of a significant interaction 
between vaccine and challenge.  Post-challenge mortality was analyzed in a similar 
fashion following a square root arc sin transformation.  Significance was determined at P 
< 0.05, and means were separated using Duncan’s Multiple Range Test. 
  
61
Experiment 4  
 Pre-challenge data were analyzed using a 3 x 2 factorial analysis of variance.  
Differences in main effects were deemed significant a P < 0.05 and means were 
separated using a Duncan’s Multiple Range Test.  Post-challenge data were analyzed 
using a one-way analysis of variance due to a significant interaction present between 
vaccine and challenge.  Means were separated using a Duncan’s Multiple Range Test at 
P < 0.05. Post-challenge mortality was analyzed in similar fashion following a square 
root arc sin transformation. 
Results 
Experiment 1 
 Average broiler body weights at d 21 increased as protein level in the diet 
increased (Table 3-2).  The 20% protein starter diet yielded lower (P<0.05) average body 
weights compared to all other treatments.  The 24% protein diet yielded higher (P<0.05) 
average body weights compared to the 21 and 22% protein starter diets while the 21, 22, 
and 23% protein starter diets were similar.  Feed conversion results yielded an inverse 
relationship as body weight with increasing protein level reducing mortality corrected 
feed conversion of vaccinated broilers at 21 d of age.  The 20% protein diet resulted in a 
higher (P<0.05) feed conversion ratio compared to all other treatments.   Increasing 
dietary protein concentration to 21% lowered (P<0.05) feed conversion ratio compared 
to the 20% protein level.  A further increase in protein level to 22 and 23% further 
reduced (P<0.05) feed conversion ratios while the 24% protein starter diet resulted in a  
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Table 3-2.  Average body weights (g) and mortality corrected feed conversion ratios ± 
SEM of live oocyst vaccinated (Coccivac®-B) broilers at day 21 fed selected 
concentrations of protein (Experiment 1). 
 
Protein (%)       Body Weight (g)              Feed:Gain 
20    585 ± 12c   1.57 ± 0.03a 
21    665 ± 5b   1.40 ± 0.02b 
22    679 ± 11b   1.35 ± 0.01c 
23    689 ± 14ab   1.34 ± 0.02c 
24    720 ± 9a   1.27 ± 0.01d 
a-d Means with different superscripts within columns differ significantly at P<0.05.
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lower (P<0.05) mortality corrected feed conversion ratio compared to all other levels.  
Average body weights and mortality corrected feed conversion ratios of vaccinated 
broilers fed 20, 22, and 24% dietary protein levels were significantly different from each 
other at 21 d of age.  Therefore, these three protein levels were selected for use in 
Experiments 2 and 3.  
Experiment 2 
 Average body weights of broilers at 21 d followed a similar trend as reported in 
Experiment 1, increasing dietary protein level increased average body weights of 
broilers (Table 3-3).  In non-vaccinated broilers, increases (P<0.05) in average body 
weights were observed with each increase in dietary protein level.  The 20% protein 
level resulted in the lowest body weight and the 24% protein level resulted in the 
heaviest body weights.  Body weights for vaccinated broilers followed a similar trend.  
The 20% protein level resulted in lower (P<0.05) body weights than the 22 and 24% 
starter diets.  An increase in body weight due to increased protein concentration from 
22% to 24% was not observed in vaccinated broilers.  Vaccinated broilers fed the lowest 
protein concentration in the starter diet were the lightest broilers compared to all other 
treatments.  Vaccination of broilers reduced (P<0.05) body weights at the 20 and 24% 
protein levels compared to the non-vaccinated broilers fed the same protein level.  
However, the vaccinated broilers fed 22% protein were similar to non-vaccinated 
broilers fed the same protein concentration.   
Mortality corrected feed conversion ratios at 21 d also followed similar trends as 
in Experiment 1; increasing protein level reduced feed conversion ratios of both  
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Table 3-3.  Average body weights (g) and mortality corrected feed conversion ratios ± 
SEM of non-vaccinated and vaccinated (Coccivac®-B) broilers at day 21 fed diets 
containing three different protein concentrations (Experiment 2). 
 
Protein (%) Treatment         Body Weight (g)              Feed:Gain 
20  Non-vaccinated 664 ± 18c   1.40 ± 0.03b 
20  Vaccinated  579 ±   8d   1.60 ± 0.02a 
22  Non-vaccinated 733 ± 33b   1.30 ± 0.01cd 
22  Vaccinated  709 ± 14bc   1.34 ± 0.02bc 
24  Non-vaccinated 808 ± 10a   1.26 ± 0.01d 
24  Vaccinated  737 ± 17b   1.31 ± 0.02cd 
a-d Means with different superscripts within columns differ significantly at P<0.05.
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vaccinated and non-vaccinated broilers (Table 3-3).  Broilers fed the 20% protein diet 
yielded higher (P<0.05) feed conversion ratios compared to the 22% and 24% levels 
regardless of vaccination.  Vaccination caused an increase (P<0.05) in feed conversion at 
lowest protein level investigated.  However, at the two highest protein levels fed, there 
were no differences between vaccinated and non-vaccinated broilers with respect to feed 
conversion at the same dietary protein level. 
 Body weight gain and mortality corrected feed conversion ratios during the 
challenge period (21 d to 27 d) were similar for non-vaccinated and vaccinated non-
challenge broilers at all protein levels (Table 3-4).  In challenged broilers, vaccination 
increased (P<0.05) body weight gain compared to non-vaccinated broilers at all protein 
levels investigated.  Non-vaccinated challenge broilers had similar weight gain at all 
protein levels during the challenge period which were lower (P<0.05) than all other 
treatments.  Within the vaccinated challenge broilers, increased (P<0.05) weight gains 
were observed in broilers fed the 24% protein diet compared to the 20% protein level 
while the 22% level was intermediate.  Mortality corrected feed conversion ratios during 
the challenge period for vaccinated challenge broilers were similar at all protein levels.  
In lieu of challenge, vaccinated broilers yielded similar feed conversion ratios as all non-
challenged treatment groups.  Challenge of non-vaccinated broilers resulted in higher 
(P<0.05) feed conversion ratios compared to all other treatment groups.  In non-
vaccinated challenged broilers, post-challenge feed conversion ratios were decreased 
(P<0.05) with each increase in dietary protein level.  Increased protein concentration 
improved broiler performance during Eimeria challenge with increased body weight  
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Table 3-4.  Average body weight gains (g), mortality corrected feed conversion ratios 
(FCR), and mortality ± SEM of non-vaccinated (NV) and vaccinated (V) (Coccivac®-B) 
broilers six days post mixed species Eimeria challenge at day 21 fed diets containing 
three different protein concentrations (Experiment 2). 
 
Protein   Vaccine       Chall1  BW Gain     FCR                 FCR            Post-challenge 
(%)            (g)  Day 21-27 Day 1 -27    Mortality2 
20      NV  No 392 ±   7a 1.59 ± 0.02d 1.49 ± 0.03d 0.07 ± 0.07bc 
20      V  No 377 ± 32a 1.61 ± 0.05d 1.60 ± 0.02c 0.00 ± 0.00c 
22        NV  No 402 ±   8a 1.39 ± 0.16d 1.38 ± 0.01e 0.00 ± 0.00c 
22      V  No 406 ± 16a 1.52 ± 0.04d 1.41 ± 0.02e 0.00 ± 0.00c 
24      NV  No 415 ± 15a 1.49 ± 0.02d 1.35 ± 0.01e 0.07 ± 0.07bc 
24      V  No 396 ± 12a 1.49 ± 0.02d 1.35 ± 0.01e 0.00 ± 0.00c 
20      NV  Yes   63 ± 17d 5.80 ± 0.46a 1.78 ± 0.03a 0.35 ± 0.09a 
20      V  Yes 236 ± 21c 2.05 ± 0.09d 1.74 ± 0.05a 0.16 ± 0.08abc 
22      NV  Yes   96 ±   6d 4.61 ± 0.22b 1.67 ± 0.01b 0.33 ± 0.03a 
22      V  Yes 278 ± 19bc 1.89 ± 0.03d 1.50 ± 0.01d 0.07 ± 0.07bc 
24      NV  Yes   84 ± 28d 3.91 ± 0.60c 1.59 ± 0.05c 0.23 ± 0.12ab 
24      V  Yes 316 ± 24b 1.90 ± 0.03d 1.50 ± 0.01d 0.19 ± 0.10abc 
a-e Means with different superscripts within columns differ significantly at P<0.05. 
1 Mixed species challenge contained Eimeria acervulina (6 x 105), Eimeria maxima (4 x 105), and Eimeria 
tenella (2 x 105) sporulated oocysts. 
2 Reported values are a result of a square root arc sin transformation of the observed mortality rates. 
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gain in vaccinated broilers and decreased feed conversion ratios in non-vaccinated 
broilers. 
Cumulative mortality corrected feed conversion ratios for 1 to 27 d were similar 
in non-vaccinated and vaccinated non-challenged broilers at both 22 and 24% protein 
levels.  Non-challenged broilers fed the 20% protein diet had a higher (P<0.05) feed 
conversion ratio compared to the 22 and 24% protein levels.  Vaccination caused an 
increase (P<0.05) in cumulative feed conversion at the 20% level in non-challenged 
broilers but had no adverse effect in non-challenged broilers fed the 22 and 24%.  In 
challenged broilers, vaccination led to a decrease (P<0.05) in cumulative feed 
conversion ratio in the 22 and 24% protein fed broilers compared to non-vaccinated 
challenge broilers while the 20% protein level was similar for both vaccinated and non-
vaccinated challenged broilers.  Increased dietary protein led to decreased (P<0.05) 
cumulative feed conversion ratios in non-vaccinated challenged broilers.  Vaccination 
resulted in decreased (P<0.05) mortality in the 22% protein fed challenged broilers 
compared to the 20 and 22% non-vaccinated challenge broilers while all other challenge 
groups had similar mortality rates. 
Overall, lesion development was decreased in vaccinated challenged broilers 
compared non-vaccinated challenged broilers (Table 3-5).  Overall lesions in the upper 
small intestine indicative of E. acervulina were minimal.  All vaccinated challenged 
broilers had (P<0.05) lower lesion development in the upper small intestine compared to 
the 22 and 24% protein fed non-vaccinated challenged broilers.  Mid intestinal lesion 
development associated with E. maxima was decreased (P<0.05) in the 24% protein fed  
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Table 3-5.  Lesion scores of non-vaccinated and vaccinated (Coccivac®-B) broilers six 
days post mixed species Eimeria challenge at day 21of half of the treatment groups fed 
diets containing three different protein concentrations (Experiment 2). 
 
Protein      Vaccination Challenge1     Upper      Mid     Lower 
(%)           
20      Non-vaccinated No  0.26 ± 0.08bc 0.40 ± 0.02e 0.00 ± 0.00d 
20      Vaccinated  No  0.00 ± 0.00d 0.87 ± 0.05de 0.23 ± 0.12d 
22        Non-vaccinated No  0.00 ± 0.00d 0.64 ± 0.16e 0.04 ± 0.04d 
22      Vaccinated  No  0.00 ± 0.00d 0.87 ± 0.04de 0.03 ± 0.03d 
24      Non-vaccinated No  0.10 ± 0.05cd 0.47 ± 0.02e 0.00 ± 0.00d 
24      Vaccinated  No  0.00 ± 0.00d 0.60 ± 0.02e 0.07 ± 0.04d 
20      Non-vaccinated Yes  0.13 ± 0.08cd 2.13 ± 0.46a 2.17 ± 0.11a 
20      Vaccinated  Yes  0.00 ± 0.00d 1.90 ± 0.09ab 0.60 ± 0.15c 
22      Non-vaccinated Yes  0.33 ± 0.09b 1.83 ± 0.22ab 2.03 ± 0.11a 
22      Vaccinated  Yes  0.03 ± 0.03d 1.57 ± 0.03bc 0.77 ± 0.17c 
24      Non-vaccinated Yes  0.53 ± 0.15a 1.93 ± 0.60ab 2.03 ± 0.11a 
24      Vaccinated  Yes  0.00 ± 0.00d 1.20 ± 0.03cd 1.40 ± 0.20b 
a-e Means with different superscripts within columns differ significantly at P<0.05. 
1 Mixed species challenge contained Eimeria acervulina (6 x 105), Eimeria maxima (4 x 105), and Eimeria 
tenella (2 x 105) sporulated oocysts.
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vaccinated challenged broilers compared to the 24% non-vaccinated challenged broilers.  
Numeric decreases in mid intestinal lesion scores were observed in vaccinated challenge  
broilers at the 20 and 22% levels compared to non-vaccinated challenged broilers.  
Lower intestinal lesion development associated with E. tenella challenge was decreased 
(P<0.05) in vaccinated challenge broilers compare to non-vaccinated challenge broilers 
at all protein levels.  Lower intestinal lesion scores were similar for all non-vaccinated 
challenge broilers while vaccinated challenged broilers fed 24% protein had significantly 
increased lower intestinal lesion scores compare to the 20 and 22% vaccinated challenge 
broilers.  An inverse relationship existed between mid and lower intestinal lesion 
development in vaccinated challenged broilers fed different dietary protein levels.  Mid 
intestinal lesions decreased with increasing protein level while lower intestinal lesion 
development increased with increasing protein level.  Lesions were observed in a small 
percentage of non-challenged broilers.  The lesions present in the non-vaccinated non-
challenge broilers may be attributed to the close proximity in which broilers were reared 
while the lesions present in the vaccinated non-challenged broilers may be due to 
continued cycling of vaccine oocysts or the close proximity of rearing.   Housing both 
challenged and non-challenged broilers in close proximity to each other was essential in 
order to assure no environmental or pen-related effects on performance throughout the 
duration of the experiment.    
Experiment 3  
Experiment 3 was conducted to further investigate the inverse relationship 
between mid and lower intestinal lesion development and protein level in challenge 
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broilers as well as to validate the results observed in Experiment 2.  The interaction 
observed in Experiment 2 between protein level and vaccination was not observed in 
Experiment 3 pre-challenge.  Therefore, main effects will be discussed as opposed to 
individual treatments.  Average body weights on d 21 of broilers fed 22 and 24% protein 
starter diets were higher (P<0.05) compared to the 20% protein level (Table 3-6).  
Vaccinated broilers had lower (P<0.05) body weights at 21d as compared to non-
vaccinated broilers.  Mortality corrected feed conversion ratios followed similar patterns 
observed in the previous two experiments.  Broilers fed a starter diet containing 20% 
protein had increased (P<0.05) feed conversion ratios compared to 22 and 24% protein 
fed broilers, and vaccination increased (P<0.05) feed conversion ratios at d 21.   
Body weight gains were similar for non-vaccinated and vaccinated non-
challenged broilers regardless of protein level with one exception.  The 20% vaccinated 
broilers gained less (P<0.05) weight during the six day post challenge period (20 d to 26 
d) compared to the 22% non-vaccinated broilers (Table 3-7).  Vaccinated challenge 
broilers gained more (P<0.05) body weight during the challenge period compared to all 
non-vaccinated challenged broilers.  Body weight gain for all non-vaccinated challenged 
broilers was similar at all protein levels.  The 22% vaccinated challenged broilers gained 
more (P<0.05) body weight compared to the 20 and 24% vaccinated challenged broilers.  
Body weight gain of the 22% vaccinated challenged broilers were increased to a level 
similar to several non-challenged treatment groups.   
Mortality corrected feed conversion ratios during the challenge period were 
similar for all non-challenge treatments, thus vaccination did not have an adverse effect  
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Table 3-6. Average body weights (g) and mortality corrected feed conversion ratios ± 
SEM of non-vaccinated and vaccinated (Coccivac®-B) broilers at day 20 fed diets 
containing three different protein concentrations (Experiment 3).    
       
Body Weight (g) 
Protein       Treatment     
         Non-Vaccinated             Vaccinated     Mean 
20   720 ± 11   679 ± 14   699 ± 11b 
22   780 ±   5   750 ±   9  765 ±   7a 
24   793 ±   9   739 ±   5  762 ± 12a 
Mean   762 ± 11a   723 ± 11b 
Feed:Gain 
Protein        Treatment     
           Non-Vaccinated              Vaccinated     Mean 
20   1.49 ± 0.01   1.55 ± 0.02  1.52 ± 0.01a 
22   1.34 ± 0.01   1.42 ± 0.04  1.38 ± 0.03b 
24   1.30 ± 0.01   1.38 ± 0.02  1.34 ± 0.02b 
Mean   1.38 ±0.03b   1.45 ±0.03a 
a,b Means of main effects with different superscripts differ significantly at P<0.05. 
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Table 3-7.  Average body weight gains (g), mortality corrected feed conversion ratios 
(FCR), and mortality ± SEM of non-vaccinated (NV) and vaccinated (V) (Coccivac®-B) 
broilers six days post mixed species Eimeria challenge at day 20 fed diets containing 
three different protein concentrations (Experiment 3). 
 
Protein   Vaccine       Chall1  BW Gain     FCR                FCR            Post-challenge 
(%)            (g)  Day 20-26 Day 1 -26    Mortality2 
20      NV  No 391 ±   5abc 1.66 ± 0.01c 1.55 ± 0.01cd 0.00 ± 0.00b 
20      V  No 382 ±   5bc 1.70 ± 0.05bc 1.61 ± 0.01bc 0.14 ± 0.13b 
22        NV  No 441 ± 30a 1.52 ± 0.02c 1.40 ± 0.01e 0.00 ± 0.00b 
22      V  No 438 ± 15ab 1.53 ± 0.01c 1.43 ± 0.01e 0.00 ± 0.00b 
24      NV  No 414 ± 24abc 1.52 ± 0.02c 1.38 ± 0.02e 0.00 ± 0.00b 
24      V  No 429 ±   8abc 1.52 ± 0.05c 1.43 ± 0.04e 0.00 ± 0.00b 
20      NV  Yes 197 ± 26e 2.65 ± 0.23a 1.72 ± 0.05a 0.41 ± 0.04a 
20      V  Yes 305 ±   3d 1.99 ± 0.06b 1.68 ± 0.01ab 0.18 ± 0.00ab 
22      NV  Yes 191 ±   3e 2.57 ± 0.04a 1.58 ± 0.01cd 0.13 ± 0.13b 
22      V  Yes 380 ±   2c 1.60 ± 0.06c 1.51 ± 0.03d 0.13 ± 0.13b 
24      NV  Yes 193 ±   5e 2.47 ± 0.04a 1.55 ± 0.01cd 0.10 ± 0.09b 
24      V  Yes 309 ± 17d 1.80 ± 0.03bc 1.51 ± 0.01d 0.10 ± 0.09b 
a-e Means with different superscripts within columns differ significantly at P<0.05. 
1 Mixed species challenge contained Eimeria acervulina (6 x 105), Eimeria maxima (4 x 105), and Eimeria 
tenella (2 x 105) sporulated oocysts. 
2 Reported values are a result of a square root arc sin transformation of the observed mortality rates.
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on feed conversion during this period of grow-out.  Introduction of a mixed species 
challenge resulted in an increase (P<0.05) in feed conversion ratios of non-vaccinated  
broilers compared to all other treatments groups.  An effect of protein level on feed 
conversion ratio of non-vaccinated challenged broilers was not observed.  Feed 
conversion of 20% vaccinated challenged broilers was higher (P<0.05) compared to the 
22% vaccinated challenged broilers.  Vaccinated challenged broilers fed 22 and 24% 
protein diets resulted in feed conversion ratios similar to all non-challenged treatments.  
Cumulative mortality corrected feed conversion ratios for vaccinated non-challenged 
broilers were similar to non-vaccinated non-challenged broilers within each protein 
treatment.  Non-challenged broilers fed 20% protein yielded higher (P<0.05) feed 
conversion ratios compared to the 22 and 24% protein levels.  Non-challenged broilers 
fed 22 and 24% protein levels had lower (P<0.05) feed conversion ratios than all 
challenged treatments.  Although numeric reductions in cumulative feed conversions 
were observed in vaccinated challenged broilers compared to non-vaccinated challenged 
broilers, these did not reach the level of significance.  Post-challenge mortality was 
increased (P<0.05) in 20% non-vaccinated challenged broilers compared to all other 
challenged groups and non-challenged groups with the exception of the 20% vaccinated 
challenged broilers.   
As in Experiment 2, in most instances, lesion development was reduced in 
vaccinated challenged broilers compared to non-vaccinated broilers (Table 3-8).  Lesion 
development in the upper small intestine associated with E. acervulina was reduced 
(P<0.05) in vaccinated challenged broilers compared to non-vaccinated challenged  
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Table 3-8.  Lesion scores of non-vaccinated and vaccinated (Coccivac®-B) broilers six 
days post mixed species Eimeria challenge at day 20 fed diets containing three different 
protein concentrations (Experiment 3). 
 
Protein      Vaccination Challenge1     Upper            Mid      Lower 
(%)           
20      Non-vaccinated No  0.00 ± 0.00c 0.33 ± 0.10d 0.03 ± 0.03d 
20      Vaccinated  No  0.10 ± 0.06c 0.50 ± 0.10cd 0.10 ± 0.06cd 
22        Non-vaccinated No  0.10 ± 0.06c 0.73 ± 0.15cd 0.03 ± 0.03d 
22      Vaccinated  No  0.23 ± 0.10c 1.03 ± 0.20bc 0.07 ± 0.05cd 
24      Non-vaccinated No  0.03 ± 0.03c 0.77 ± 0.11cd 0.07 ± 0.05cd 
24      Vaccinated  No  0.00 ± 0.00c 0.87 ± 0.11c 0.00 ± 0.00d 
20      Non-vaccinated Yes  1.29 ± 0.20a 1.55 ± 0.18a 1.00 ± 0.16a 
20      Vaccinated  Yes  0.23 ± 0.08c 1.87 ± 0.21a 0.37 ± 0.09bc 
22      Non-vaccinated Yes  1.03 ± 0.22a 1.90 ± 0.21a 1.00 ± 0.15a 
22      Vaccinated  Yes  0.07 ± 0.05c 0.90 ± 0.15c 0.20 ± 0.09cd 
24      Non-vaccinated Yes  0.57 ± 0.11b 1.50 ± 0.20ab 0.80 ± 0.15a 
24      Vaccinated  Yes  0.10 ± 0.06c 0.83 ± 0.21cd 0.50 ± 0.12b 
a-d Means with different superscripts within columns differ significantly at P<0.05. 
1 Mixed species challenge contained Eimeria acervulina (6 x 105), Eimeria maxima (4 x 105), and Eimeria 
tenella (2 x 105) sporulated oocysts.
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broilers at all protein levels.  The highest dietary protein level, 24%, resulted in reduced 
upper intestinal lesion development in non-vaccinated challenge broilers compared to 
the two lower protein levels.  Reductions (P<0.05) were observed in 22% and 24% 
protein fed vaccinated challenged broilers compared to all other challenged groups.  No 
protection with respect to E. maxima challenge was observed in 20% protein fed 
vaccinated broilers, as lesion development in this group was similar to non-vaccinated 
challenge groups.  Vaccinated challenged broilers fed either 22 or 24% protein had 
lower (P<0.05) lesion development associated with E. maxima compared to non-
vaccinated challenged groups.  Lower intestinal lesions associated with E. tenella were 
reduced (P<0.05) due to vaccination.  Vaccinated challenged broilers had lower (P<0.05) 
lesion scores compared to non-vaccinated challenged broilers regardless of protein level.  
Due to the interaction present, it is difficult to use these data to completely identify the 
effect of protein level on lesion development due to challenge. 
Experiment 4 
 Results from the previous three experiments indicate that performance 
parameters of vaccinated broilers were not enhanced by increasing the protein level 
above 22%.  Experiment 4 investigated the effects of the duration of the starter phase on 
broiler performance during vaccination and subsequent challenge.  Average body 
weights for vaccinated and non-vaccinated broilers were similar (P>0.05) at 13 d of age 
(Table 3-9).  Vaccinated broilers had lower (P<0.05) average body weights compared to 
non-vaccinated broilers at 17 d of age.  At 17 d of age, no differences existed between 
broilers fed the starter diet for 13 d as opposed to 17 d.  On 21 d of age, vaccinated  
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Table 3-9.  Average body weights ± SEM of non-vaccinated and vaccinated 
(Coccivac®-B) broilers fed a starter diet for three different durations (Experiment 4). 
 
Starter Duration (d)  Treatment      Body Weight (g)               
Day 13 
   Non-vaccinated 373 ±   4    
   Vaccinated  375 ±   3    
Day 17 
Duration (d)    Treatment 
  Non-vaccinated  Vaccinated  Means 
13  562 ±  7   537 ± 10  549 ±  7 
17  566 ±  5   551 ±   8  559 ±  5 
Means  564 ±  4a   546 ±  7b 
Day 21 
Duration (d)    Treatment 
  Non-vaccinated  Vaccinated  Means 
13  757 ± 16   715 ± 19  736 ± 14 
17  767 ± 10   757 ± 14  762 ±   8 
21  777 ±   6   739 ± 15  760 ± 18 
Means  767 ±  6a   737 ± 13b 
a,b Means with different superscripts within columns differ significantly at P<0.05.
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broilers had lower (P<0.05) average body weights compared to non-vaccinated broilers 
while duration of starter period had no effect on average body weight.  Mortality  
corrected feed conversion ratios at 13 d were similar (P>0.05) for vaccinated and non-
vaccinated broilers (Table 3-10), and similar (P>0.05) results were observed on 17 d and 
21 d.  Vaccination had no adverse effects on feed conversion ratios during the first 21 d 
of age. Increased starter period duration resulted in decreased feed conversions on d 21.  
Broilers switched to the grower diet on d 13 had an increased (P<0.05) feed conversion 
compared to broilers switched to the grower diet on d 17 and d 21.  This was the only 
adverse effect observed associated with shorter starter phase duration. 
 During the challenge period (21d to 27d of age), body weight gains were similar 
for all non-vaccinated and vaccinated non-challenged treatments.  In challenged broilers, 
all vaccinated treatment groups gained more (P<0.05) body weight than non-vaccinated 
broilers (Table 3-11).  No effect of starter phase duration was observed on weight gain 
during the challenge period.  Mortality corrected feed conversion ratios were similar for 
vaccinated and non-vaccinated non-challenged broilers during the challenge period.  In 
challenged broilers, vaccination resulted in decreased (P<0.05) feed conversions 
compared to non-vaccinated broilers post-challenge. Cumulative feed conversion ratios 
(1d to 27d) were similar for all non-challenged treatments.  All cumulative feed 
conversion ratios were higher (P<0.05) in challenged broilers compared to non-
challenged broilers.  Cumulative feed conversion ratios in vaccinated challenged broilers 
fed the starter diet for 21 d duration period were reduced (P<0.05) compared to the non-
vaccinated challenged broilers fed the starter diet for 13 and 17 d.  Post-challenge  
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Table 3-10.  Mortality corrected feed conversion ratios ± SEM of non-vaccinated and 
vaccination (Coccivac®-B) broilers fed a starter diet for three different durations 
(Experiment 4). 
 
Starter Duration (d) Treatment           Feed:Gain 
Day 1 to 13 
   Non-vaccinated 1.10 ± 0.01 
   Vaccinated  1.10 ± 0.01 
Day 1 to 17 
Duration (d)    Treatment 
  Non-vaccinated  Vaccinated  Means 
13  1.30 ± 0.01   1.32 ± 0.02  1.31 ± 0.02 
17  1.28 ± 0.02   1.30 ± 0.02  1.29 ± 0.02 
Means  1.29 ± 0.01   1.31 ± 0.02 
Day 1 to 21 
Duration (d)    Treatment 
  Non-vaccinated  Vaccinated  Means 
13  1.40 ± 0.02   1.47 ± 0.04  1.44 ± 0.03a 
17  1.36 ± 0.02   1.37 ± 0.01  1.37 ± 0.01b 
21  1.34 ± 0.01   1.37 ± 0.02  1.35 ± 0.01b 
Means  1.37 ± 0.01   1.41 ± 0.02 
a,b Means with different superscripts within columns differ significantly at P<0.05. 
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Table 3-11.  Average body weight gains (g), mortality corrected feed conversion ratios 
(FCR), and mortality ± SEM of non-vaccinated (NV) and vaccinated (V) (Coccivac®-B) 
broilers six days post mixed species Eimeria challenge at day 21 fed a starter diet for 
three different durations (Experiment 4). 
 
Duration  Vaccine       Chall1  BW Gain      FCR     FCR            Post-challenge 
(d)            (g)  Day 21-27 Day 1 -27    Mortality2 
13      NV  No 418 ± 63a 1.54 ± 0.19b 1.46 ± 0.07c 0.07 ± 0.07b 
13      V  No 435 ± 25a 1.34 ± 0.07b 1.41 ± 0.05c 0.00 ± 0.00b 
17        NV  No 448 ± 32a 1.44 ± 0.05b 1.41 ± 0.01c 0.00 ± 0.00b 
17      V  No 403 ± 24a 1.55 ± 0.02b 1.44 ± 0.01c 0.00 ± 0.00b 
21      NV  No 409 ± 48a 1.72 ± 0.24b 1.46 ± 0.06c 0.00 ± 0.00b 
21      V  No 441 ± 15a 1.47 ± 0.04b 1.43 ± 0.02c 0.00 ± 0.00b 
13      NV  Yes   81 ± 11c 5.77 ± 0.50a 1.73 ± 0.02a 0.49 ± 0.04a 
13      V  Yes 242 ± 14b 2.01 ± 0.22b 1.62 ± 0.03ab 0.14 ± 0.07b 
17      NV  Yes 102 ±   2c 5.43 ± 0.32a 1.73 ± 0.01a 0.49 ± 0.02a 
17      V  Yes 210 ± 11b 2.70 ± 0.14b 1.65 ± 0.01ab 0.14 ± 0.07b 
21      NV  Yes 113 ± 36c 4.84 ± 0.58a 1.67 ± 0.03ab 0.36 ± 0.04a 
21      V  Yes 271 ± 22b 2.27 ± 0.12b 1.59 ± 0.05b 0.08 ± 0.08b 
a-c Means with different superscripts within columns differ significantly at P<0.05. 
1 Mixed species challenge contained Eimeria acervulina (1.25 x 106), Eimeria maxima (4 x 105), and 
Eimeria tenella (5 x 104) sporulated oocysts. 
2 Reported values are a result of a square root arc sin transformation of the observed mortality rates.
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mortality was higher (P<0.05) in non-vaccinated challenged groups compared to all 
other treatments while mortality for vaccinated challenged broilers was similar to all  
non-challenged broilers.  An effect of starter phase duration on post-challenge mortality 
was not observed.  Lesion development associated with the mixed species challenge was 
unaffected by starter phase duration time.  However, lesion development was reduced 
(P<0.05) in the upper and lower intestinal segments in vaccinated challenged broilers 
compared to non-vaccinated challenged broilers (Table 3-12).  While lesion 
development associated with the E. maxima challenge was numerically reduced in 
vaccinated challenged broilers compared to non-vaccinated challenged broilers, only 
broilers switched to grower on d 13 of age reached the level of significance.   
Discussion 
Increasing dietary protein level improved broiler performance at 21 d of age, 
determined by body weights and feed conversion, regardless of vaccination.  This 
observation was expected as many reports have correlated crude protein level of diets to 
broiler performance (Sterling et al. 2003; Vieira et al., 2004).  Crude protein level of 
diets is of extreme importance due to the cost associated with increasing the protein level 
in diets, which leads to impacts on costs as well as revenues during broiler meat 
production (Eits et al., 2005).  In Experiment 1, a linear relationship was observed with 
respect to body weight and feed conversion associated with increased crude protein level 
to 21 d of age in vaccinated broilers.  Broilers fed 20, 22, or 24% protein in the starter 
diet to 21 d of age differed significantly in performance characteristics.  Therefore, these  
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Table 3-12.  Lesion scores of non-vaccinated and vaccinated (Coccivac®-B) broilers six 
days post mixed species Eimeria challenge at day 21 fed a starter diet for three different 
durations (Experiment 4). 
 
Duration     Vaccination Challenge1          Upper           Mid       Lower 
(day)           
13      Non-vaccinated No  0.03 ± 0.03c 0.13 ± 0.06d 0.00 ± 0.00d 
13      Vaccinated  No  0.00 ± 0.00c 0.60 ± 0.11c 0.10 ± 0.06d 
17        Non-vaccinated No  0.00 ± 0.00c 0.07 ± 0.05d 0.00 ± 0.00d 
17      Vaccinated  No  0.03 ± 0.03c 0.63 ± 0.10c 0.03 ± 0.03d 
21      Non-vaccinated No  0.00 ± 0.00c 0.13 ± 0.06d 0.00 ± 0.00d 
21      Vaccinated  No  0.00 ± 0.00c 0.47 ± 0.09cd 0.03 ± 0.03d 
13      Non-vaccinated Yes  1.40 ± 0.18ab 2.30 ± 0.15a 2.10 ± 0.15a 
13      Vaccinated  Yes  0.23 ± 0.09c 1.70 ± 0.20b 0.63 ± 0.15c 
17      Non-vaccinated Yes  1.47 ± 0.21a 2.37 ± 0.17a 2.23 ± 0.16a 
17      Vaccinated  Yes  0.13 ± 0.08c 2.07 ± 0.20ab 1.13 ± 0.21b 
21      Non-vaccinated Yes  1.13 ± 0.13b 2.13 ± 0.15a 2.30 ± 0.14a 
21      Vaccinated  Yes  0.10 ± 0.06c 2.07 ± 0.18ab 1.13 ± 0.17b 
a-d Means with different superscripts within columns differ significantly at P<0.05. 
1 Mixed species challenge contained Eimeria acervulina (1.25 x 106), Eimeria maxima (4 x 105), and 
Eimeria tenella (5 x 104) sporulated oocysts.
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protein levels were selected for use in subsequent experiments to compare growth 
characteristics to non-vaccinated broilers during field strain Eimeria challenge.   
Non-vaccinated broilers indicated similar patterns in performance characteristics as 
vaccinated broilers with improvement in performance characteristics related to increased 
protein level of the diet.  Vaccination tended to reduce body weight and increase feed 
conversion compared to non-vaccinated broilers prior to challenge.  However, in 
Experiment 2 where an interaction was observed and data were analyzed by one-way 
analysis, vaccinated broilers fed 22% protein had similar growth characteristics 
compared to the non-vaccinated broilers fed the 22% starter diet.  Reduced body weights 
and increased feed conversion ratios during the early stages of growth due to vaccination 
have been reported by other investigators (Danforth, 1998; Williams, 2002).  However, 
other published reports have indicated that compensatory gain in vaccinated broilers 
during subsequent dietary periods results in similar if not improved performance 
characteristics at the completion of grow-out (Danforth, 1998; Williams et al., 1999; 
Williams and Gobbi, 2002; Williams, 2002).   
During the six day challenge period which began on d 21 (Experiment 2 and 4) 
or d 20 (Experiment 3), vaccination did not adversely effect body weight gain and feed 
conversion ratios.  Similarly, increasing dietary protein had no effect on performance 
parameters during this six day period.  Over the duration of the experiment, feed 
conversion ratios of non-challenged broilers were unaffected due to vaccination with 
respect to the 22 and 24% dietary level.  Non-challenged broilers regardless of 
immunization status fed the 20% dietary protein level had increased feed conversion 
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ratios compared to broilers fed the 22 and 24% dietary protein levels.  However, 
vaccination significantly increased feed conversion ratio of vaccinated broilers fed 20% 
protein compared to non-vaccinated broilers fed 20% protein in one experiment.  Diets 
containing the lowest protein level in these experiments tended to have a larger impact 
on performance characteristics due to vaccination.   The highest dietary protein level 
(24%) did not necessarily translate to the highest level of performance in vaccinated and 
challenged chickens, as the 22% protein level was often indistinguishable from the 24% 
level.  In Experiment 2, performance values of chickens fed a 22% dietary protein level 
did not differ between vaccinated and non-vaccinated groups prior to or during 
challenge. 
The generation of immunity through vaccination improved performance of 
broilers during Eimeria challenge has been widely reported (Brake et al., 1997b; Weber 
and Evans, 2003; Williams, 2003; Shirley et al., 2005) and was evident by significantly 
higher body weight gain, reduced feed conversion ratios, reduced lesion development, 
and in some cases reduced mortality post-challenge compared to non-vaccinated 
broilers.  Improved growth characteristics during the challenge period in vaccinated 
broilers led to significantly improved cumulative feed conversion ratios (d 1-27) in 
broilers fed the two higher protein levels in Experiment 2.   
In Experiment 2, increasing dietary protein tended to reduce lesion development 
associated with E. maxima while tending to increase lesion development associated with 
E. tenella in vaccinated chickens.  This trend was also observed in Experiment 3, 
decreased lesion development associated with E. maxima was observed with increased 
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protein level although lesion development in the lower intestine was not different.  This 
may be attributed to the overall lower lesion development observed in Experiment 3 in 
the lower intestine.  These data tend to indicate an inverse relationship in lesion develop 
associated with E. maxima and E. tenella during a mixed species challenge in vaccinated 
broilers with increasing protein level.  Further investigation into the relationship of 
dietary protein level and lesion development is needed before additional conclusions can 
be drawn. 
The results obtained from the first three experiments indicate that a dietary 
protein inclusion rate of 22% in the starter diet allows for similar growth characteristics 
of vaccinated and non-vaccinated broilers.  Diets in these experiments were not changed 
according to broiler age and the starter diet was fed to d 27 which is not applicable in 
modern poultry production.  With this in mind, Experiment 4 focused on the relationship 
between vaccination and the duration of the starter period.  Vaccination had no effect on 
body weights and feed conversion ratios on d 13 of age.  Growth depression associated 
with vaccination was observed on 17 d of age, which corresponds with the second 
cycling of vaccine oocysts in the rearing environment, and continued to d 21 (Williams, 
2002).  Growth depression in vaccinated broilers fed 22% protein was also observed in 
Experiment 3 but not in Experiment 2.  Interestingly, feed conversion ratios were 
unaffected due to vaccination through d 21 with vaccinated and non-vaccinated broilers 
having similar feed conversion ratios.  Body weights were unaffected with respect to 
broiler age when changed to a grower diet although broilers changed to a grower diet on 
d 13 had a significantly higher feed conversion compared to broilers changed on d 17 or 
  
85
21.  Day of dietary change from starter to grower had no effect on body weight gain, 
feed conversion ratio, or mortality during the challenge period although vaccination did 
significantly improve all these characteristics in challenged broilers.  Non-vaccinated 
challenged broilers had a significantly higher mortality rate compared to vaccinated 
challenged broilers, a finding supported by the observations of Williams et al. (1999).    
Within these experiments, broilers immunized with Coccivac®-B had significant 
protection against lesion development associated with E. acervulina and E. tenella.  
Reductions in lesion scores, both numeric and significant, in the mid intestinal segments 
were observed but not to as great an extent as lesions present in the other two sites of 
infection.  This is most likely attributed to the immunogenic variability observed with E. 
maxima.  In order to gain significant immunization with the use of a commercially 
available live oocyst vaccine, Danforth et al. (1997b) altered the vaccine used by the 
addition of E. maxima strains isolated locally.    
Data from this series of experiments indicate that vaccination with a live oocyst 
vaccine is an effective tool for the generation of immunity to field strain Eimeria 
challenge.  Vaccination resulted in improved growth parameters in immunized compared 
to non-immunized broilers following challenge.  Further observations indicate that while 
duration of the starter period does not affect growth characteristics, dietary protein level 
is an important factor to consider when utilizing a vaccination program for the 
prevention of coccidiosis in order to maximize growth characteristics.    Increasing 
dietary protein levels may be one management consideration which might reduce or 
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eliminate the adverse effects on broiler performance due to vaccination during the starter 
period.   
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CHAPTER IV 
EVALUATION OF COCCIVAC®-B OR SALINOMYCIN FOR CONTROL OF 
FIELD STRAIN EIMERIA CHALLENGE IN BROILERS ON TWO DIFFERENT 
(SEASONAL) FEEDING PROGRAMS 
 
Introduction 
Coccidiosis is recognized as the parasitic disease that has the greatest economic 
impact on poultry production (Allen and Fetterer, 2002a).  Infection with coccidia 
parasites have been calculated to cost the US poultry industry between $450 million 
(Allen and Fetterer, 2002a) and $1.5 billion (Yun et al., 2000) annually.  Approximately 
80% of this cost is due to a decrease in performance in the presence of drug treatment 
strategies (Vermeulen et al., 2001).  There are several species of Eimeria that cause 
coccidiosis in chickens with the most prevalent being Eimeria acervulina, Eimeria 
maxima, and Eimeria tenella.  All Eimeria species parasitize the epithelial cells of the 
lining the intestine causing pathological changes varying from local destruction of the 
mucosal barrier to systemic effects such as blood loss, shock, and death (Vermeulen et 
al., 2001).  The infection leads to economic losses resulting from malabsorption of 
nutrients evidenced by decreased weight gain, increased feed conversion, and in severe 
infections, possibly increased mortality.  Historically, the poultry industry has prevented 
and controlled coccidiosis through prophylactic chemotherapy by including anticoccidial 
feed additives in rations fed to production broilers.  However, even with the 
implementation of shuttle programs for these anticoccidial feed additives, drug resistant 
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strains continue to emerge across the U.S. and the world forcing considerable interest in 
the development of alternative methods of control (Williams, 2002).   
Live oocyst vaccination is currently the only viable alternative to the use of anti-
coccidial drugs and has been used by the poultry industry for over 50 years, primarily for 
broiler breeder and replacement layer stock (Chapman et al., 2002).  The basis for their 
use is the fact that, after an infection, the host is immune to subsequent infections by the 
same species (Yun et al., 2000).  Live oocyst vaccination has been shown to be an 
effective tool for the generation of immunity and protection against subsequent Eimeria 
challenge evidenced by increased body weight gain (Danforth, 1998; Crouch et al., 
2003; Williams, 2003), reduced feed conversion (Crouch et al., 2003), and reduced 
lesion development following challenge (Danforth, 1998; Crouch et al., 2003; Williams, 
2003) in vaccinated chickens as compared to non-vaccinated chickens.  However, there 
has been a general reluctance in implementing vaccination programs in US broiler 
production due to reports of reduced performance (Allen and Fetterer, 2002a).  Non-
attenuated vaccines in broilers have been shown to decrease weight gain and increase 
feed conversion ratios when compared to medicated birds during the starter period of 
grow-out (Danforth, 1998; Williams, 2002).  Negative effects on cumulative broiler 
performance have been reported when using live oocyst vaccines compared to 
medication evidenced by reduced final body weights (Danforth et al., 1997; Waldenstedt 
et al., 1999a) and increased feed conversion ratios (Williams et al., 1999; Waldenstedt et 
al., 1999a).  Although,  Danforth (1998) and Williams and Gobbi (2002) observed that 
vaccinated broilers performed similar to if not better than medicated broilers, and that 
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vaccination can lead to significantly lower mortality rates compared to medication 
(Williams et al., 1999).  Previous research has indicated that varying dietary protein 
levels can influence performance during clinical coccidial infection (Sharma et al., 
1973). 
The objective of this study was to determine dietary influence on broiler 
performance parameters reared on litter containing locally isolated field strains of 
Eimeria while utilizing two methods of coccidiosis control.   The experimental approach 
to this trial included a comparison of the efficacy of salinomycin or Coccivac®-B when 
administered with one of two different diets that vary in protein concentration. 
Materials and Methods 
 A 2 x 2 factorial base design comparing two dietary regimens (Table 4-1) with 
two anticoccidial control measures (ionophoric chemotherapy or vaccination) was used 
to investigate broiler performance as measured by body weight and feed conversion.  
The dietary regimen consisted of four dietary phases: starter (1-14 d of age), grower (15-
29 d of age), finisher (30-40 d of age), and withdrawal (41-50 d of age).  Salinomycin 
inclusion rate was 60 g/ton for the starter and grower diets and was reduced to 50 g/ton 
in the finisher diet.  The withdrawal diet did not include salinomycin.  Chicks were 
placed in a total of 40 pens (10 replicated/treatment) with dimensions of 6 ft x 6 ft.  With 
subtracting 1 square foot for feeder space in each pen, 35 square feet of rearing space per 
pen and a placement density of 0.8 sq. ft / bird required that 43 birds be placed per 
individual pen.  The total number of birds placed was 1,720.  Every attempt was made to 
allow pens to be representative of industry operations.  Pens included one 30 lb tube  
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Table 4-1.  Calculated nutrient concentrations of experimental diets fed to broilers given one of two coccidiosis control 
measure (salinomycin or Coccivac®-B). 
 
   Starter1  Grower2  Finisher3  Withdrawal 
Diet    A B4  A B  A B  A B 
Protein (%)           21.5     22.0          20.0      19.6            16.5     17.8           15.8     17.5 
Methionine  0.58 0.59  0.55 0.56  0.44 0.50  0.42 0.49 
TSAA   0.95 0.97  0.90 0.90  0.74 0.82  0.72 0.81 
Lysine   1.22 1.27  1.14 1.12  0.90 1.00  0.85 0.95 
Threonine  0.84 0.86  0.78 0.76  0.64 0.69  0.62 0.68 
Arginine  1.44 1.47  1.32 1.29  1.05 1.15  1.01 1.13 
Tryptophan  0.25 0.26  0.23 0.22  0.17 0.19  0.17 0.19 
Calcium  1.00 1.00  0.91 0.91  0.81 0.81  0.72 0.80 
Available Phos. 0.51 0.51  0.46 0.46  0.40 0.43  0.35 0.40 
Sodium  0.22 0.22  0.23 0.23  0.23 0.23  0.23 0.23 
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Table 4-1 Continued 
     Starter1  Grower2  Finisher3  Withdrawal 
 
ME (kcal/kg)       3080    3080       3135    3135       3190    3190       3245    3245 
1 Starter diets contained 50g/ton of BMD.  Diets that utilized salinomycin for anticoccidial prevention contain 60g/ton of 
salinomycin. 
2 Grower diets contained 25g/ton of BMD and 45g/ton of roxarzone. Diets that utilized salinomycin for anticoccidial 
prevention contain 60g/ton of salinomycin. 
3 Finisher diets contained 25g/ton of BMD and 34g/ton of roxarzone. Diets that utilized salinomycin for anticoccidial 
prevention contain 50g/ton of salinomycin. 
4 Contained 0.25 lb/ton of Ethoxyquin and Vit E-125.
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feeder and nipple drinker system.  Fresh pine shavings were used as the litter material 
for each pen.  Broiler chicks were provided age appropriate supplemental heat and given 
access to feed and water ad libitum.  All animal care procedures were conducted in 
accordance with an Animal Use Protocol approved by the Texas A&M University 
laboratory animal care committee, and grow out facilities were thoroughly cleaned and 
disinfected before initiation of trial.   
On day of placement, chicks in vaccinated groups were sprayed with the 
commercially available live oocyst coccidiosis vaccine, Coccivac®-B, using a Spraycox 
2 machine at the hatchery.  Chicks were allowed to preen for at least one hour prior to 
placement on litter in floor pens.  On d 14, the litter in all pens was contaminated with 
field strain Eimeria using a garden sprayer.  The inoculum with a target dose of 40,000 
oocysts/chick consisting of E. acervulina, E. maxima, and E. tenella was prepared from 
oocysts previously isolated from commercial broiler houses in Texas.  On d 21, 7 d post-
spray application of oocysts, fresh fecal samples were obtained from a representative 
sample of pens to ensure oocyst uptake. 
Body weights and feed conversion ratios were determined on days of dietary 
changes during grow-out.  Therefore, all birds and feed were weighed on day of 
placement, and then on d 14, 29, 40, and 50 of grow-out to calculate performance 
parameters related to the experimental objective of the trial.   
Statistical Analysis 
 Statistical analysis was determined using the general linear model of SPSS V. 
11.0 (SYSTAT, 2001).  Data were analyzed using 2 x 2 factorial analysis of variance 
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with differences of main effects deemed significant at P ≤ 0.05.  A significant interaction 
was present between diet and anticoccidial control method on d 14 body weights, thus 
this data was analyzed using a one-way analysis of variance.  Means were separated 
using a Duncan’s Multiple Range Test with a significance value of P ≤ 0.05. 
Results and Discussion 
Body Weight 
 With respect to vaccination, body weights of broilers fed diet B were heavier 
(P<0.05) than broilers fed diet A on d 14 of age.  Direct comparison was done on d 14 
because of a significant interaction present between anticoccidial prevention method and 
dietary regimen.  Broilers medicated with salinomycin fed both diet A and B were 
similar (P>0.05) to both vaccinated treatments on d 14 (Table 4-2).  Through the 
remainder of the study, body weights were similar between both coccidiosis control 
methods, although body weights of vaccinated broilers were numerically higher 
compared to medicated broilers at the conclusion of the study.  With respect to dietary 
regimen, broilers fed diet B were heavier (P<0.05) on d 40, but these differences did not 
persist until d 50 with both dietary regimens yielding similar body weights at the 
completion of grow-out.  At the conclusion of the experiment on d 50, no significant 
effect (P>0.05) was observed with respect to anticoccidial control measure or dietary 
regimen.   
Mortality Corrected Feed Conversion Ratio 
 Differences were observed in mortality corrected feed conversion ratio during the 
starter period with respect to both factors, dietary regimen and anticoccidial control  
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Table 4-2.  Body weights (kg) of broilers fed two diets varying in protein level with two 
control methods for coccidiosis. 
 
Body Weight (kg) 
Day 14  
Treatment     Diet 
              A           B        Mean  
Salinomycin  0.50 ± 0.00ab  0.50 ± 0.00ab  0.50 ± 0.00  
Coccivac®-B  0.49 ± 0.01b  0.51 ± 0.00a  0.50 ± 0.00  
Mean   0.50 ± 0.00  0.50 ± 0.00    
Day 29  
Treatment     Diet 
              A           B        Mean  
Salinomycin  1.68 ± 0.01  1.68 ± 0.01  1.68 ± 0.01  
Coccivac®-B  1.65 ± 0.01  1.68 ± 0.01  1.67 ± 0.01  
Mean   1.67 ± 0.01  1.68 ± 0.01 
Day 40 
Treatment     Diet 
              A           B        Mean  
Salinomycin  2.58 ±  0.02  2.63 ± 0.02  2.61 ± 0.01  
Coccivac®-B  2.60 ± 0.02  2.65 ± 0.02  2.62 ± 0.02  
Mean   2.59 ± 0.01b  2.64 ± 0.01a 
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Table 4-2 Continued 
Body Weight (kg) 
Day 50 
Treatment     Diet 
              A           B        Mean  
Salinomycin  3.27 ± 0.01  3.30 ± 0.03  3.29 ± 0.02 
Coccivac®-B  3.31 ± 0.03  3.36 ± 0.03  3.33 ± 0.02  
Mean   3.29 ± 0.02  3.33 ± 0.02 
a,b Means with different superscripts differ at P<0.05. 
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measure (Tables 4-3 and 4-4).  Medicated broilers had a lower (P<0.05) feed conversion 
during the starter period compared to vaccinated broilers, and broilers fed diet B had a 
lower (P<0.05) feed conversion compared to broilers fed diet A.  During the grower 
period (d 14 to d 29), medicated broilers yielded a lower (P<0.05) feed conversion ratio 
compared to vaccinated broilers although no differences were observed with respect to 
diet.  During the finisher period (d 29 to d 40), broilers fed diet B yielded a lower 
(P<0.05) feed conversion ratio compared to broilers fed diet A, while no differences 
were observed during the finisher period with respect to coccidial control measure.  
During the withdrawal period (d 40 to d 50), vaccinated broilers had a lower (P<0.05) 
feed conversion ratio compared to broilers that were fed the medicated diet that 
contained salinomycin.  This increase in feed conversion is probably attributed to 
removal of salinomycin during the withdrawal phase.  No dietary effects were observed 
for the withdrawal period. 
When evaluating cumulative feed conversion during grow-out, vaccinated broilers 
yielded a higher (P<0.05) feed conversion ratio compared to medicated broilers at d 29, 
while no dietary effects were observed.  On d 40, significant differences were observed 
with respect to both factors.  Diet B fed broilers had a lower (P<0.05) feed conversion 
ratio compared to diet A, and medicated broilers had a lower (P<0.05) feed conversion 
compared to vaccinated broilers.  At the conclusion of grow-out (d 50), there were no 
differences between coccidiosis control methods although diet B yielded a lower 
(P<0.05) feed conversion compared to diet A.  The use of Coccivac®-B as a coccidiosis  
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Table 4-3. Cumulative mortality corrected feed conversion ratios of broilers fed two 
diets varying in protein level with two control methods for coccidiosis. 
 
Mortality Corrected Feed Conversion 
Day 14 
Treatment    Diet       
           A                B           Mean  
Salinomycin  1.21 ± 0.01  1.20 ± 0.01  1.21 ± 0.00b  
Coccivac®-B  1.23 ± 0.00  1.21 ± 0.00  1.22 ± 0.00a  
Mean   1.22 ± 0.01a  1.20 ± 0.00b    
Day 29 
Treatment    Diet       
           A                  B          Mean  
Salinomycin  1.44 ± 0.01  1.46 ± 0.01  1.45 ± 0.00b  
Coccivac®-B  1.48 ± 0.01  1.47 ± 0.01  1.47 ± 0.00a  
Mean   1.46 ± 0.01  1.46 ± 0.00    
Day 40 
Treatment    Diet      
           A                  B           Mean  
Salinomycin  1.66 ± 0.01  1.63 ± 0.01  1.65 ± 0.01b  
Coccivac®-B  1.69 ± 0.01  1.66 ± 0.01  1.67 ± 0.00a  
Mean   1.68 ± 0.01a  1.65 ± 0.00b    
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Table 4-3 Continued 
Mortality Corrected Feed Conversion 
Day 50 
Treatment    Diet       
           A                 B        Mean  
Salinomycin  1.90 ± 0.01  1.88 ± 0.01  1.89 ± 0.01  
Coccivac®-B  1.91 ± 0.01  1.87 ± 0.01  1.89 ± 0.01  
Mean   1.90 ± 0.01a  1.88 ± 0.01b    
a,b Means with different superscripts differ at P<0.05. 
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Table 4-4. Dietary period mortality corrected feed conversion ratios of broilers fed two 
diets varying in protein level with two control methods for coccidiosis. 
    
Mortality Corrected Feed Conversion 
 
Starter  
Treatment    Diet      
           A              B        Mean  
Salinomycin  1.21 ± 0.01  1.20 ± 0.01  1.21 ± 0.00b  
Coccivac®-B  1.23 ± 0.00  1.21 ± 0.00  1.22 ± 0.00a  
Mean   1.22 ± 0.01a  1.20 ± 0.00b     
Grower 
Treatment    Diet      
           A                   B           Mean  
Salinomycin  1.54 ± 0.01  1.56 ± 0.01  1.55 ± 0.01b  
Coccivac®-B  1.58 ± 0.01  1.58 ± 0.01  1.58 ± 0.01a  
Mean   1.56 ± 0.01  1.57 ± 0.01     
Finisher 
Treatment    Diet       
           A                    B             Mean  
Salinomycin  2.06 ± 0.02  1.94 ± 0.01  2.00 ± 0.02  
Coccivac®-B  2.06 ± 0.01  1.97 ± 0.01  2.01 ± 0.01  
Mean   2.06 ± 0.01a  1.96 ± 0.01b    
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Table 4-4 Continued 
Mortality Corrected Feed Conversion 
Withdrawal 
Treatment    Diet      
           A                   B         Mean  
Salinomycin  2.86 ± 0.06  2.90 ± 0.06  2.88 ± 0.04a  
Coccivac®-B  2.73 ± 0.04  2.70 ± 0.04  2.72 ± 0.03b  
Mean   2.80 ± 0.04  2.80 ± 0.04    
a,b Means with different superscripts differ at P< 0.05. 
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control measure yielded broilers with equivalent performance parameters compared to 
salinomycin fed broilers regardless of dietary regimen. 
The effectiveness of live oocyst vaccination in the generation of immunity and 
protection against subsequent Eimeria infection has been well documented (Danforth, 
1998; Crouch et al., 2003; Williams, 2003).  The reluctance of implementation of 
vaccination programs with the US broiler industry is due to reports of reduced 
performance associated with vaccination (Allen and Fetterer, 2002a).  The results of the 
current experiment indicate that vaccination with a live non-attenuated oocyst vaccine 
for the control of coccidiosis does not necessarily result in broilers with reduced growth 
parameters compared to medicated broilers.  These results are in agreement with 
Williams and Gobbi (2002) although these authors observed that vaccination 
significantly increased broiler body weights compared to a medication shuttle program.  
Body weights of vaccinated broilers were numerically higher in the present study 
although not significantly.  Danforth (1998) also observed similar cumulative growth 
parameters in vaccinated roasters compared to roasters fed a medicated diet with a 
shuttle program consisting of nicarbazin and narasin, although vaccination reduced body 
weights until d 35 of age.  Waldenstedt et al. (1999a) also observed significant 
reductions in body weight and increased feed conversion ratios of vaccinated broilers 
compared to medicated broilers at 36 d of age.   
Other reports have indicated reduced body weight and increased feed conversion 
ratios of vaccinated chicks compared to medicated chicks during the starter period 
(Danforth, 1998; Williams, 2002).  A post-vaccination check in body weight gain during 
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the starter period was not observed in this study with vaccinated broilers fed either 
dietary regimen having similar body weights at d 14 compared to medicated broilers, 
although an increase in feed conversion ratio was observed during the starter period in 
vaccinated chicks compared to salinomycin medicated chicks.  This increase in feed 
conversion ratio due to vaccination was also observed during the grower period; 
however, the improved performance observed during the withdrawal period due to 
vaccination eliminated these differences by the conclusion of grow-out.  Removal of 
salinomycin from the withdrawal diet of medicated broilers resulted in increased feed 
conversion ratios presumably from Eimeria exposure in combination with the lack of 
immunity in medicated broilers. Body weights of vaccinated broilers on d 14 indicate 
that reductions in early body weight can be eliminated with dietary modulation.  In 
vaccinated broilers, increased protein level in diet B resulted in higher body weights 
compared to broilers fed diet A on d 14, although this difference did not persist through 
the remainder of the trial.   
The lack of wide spread anticoccidial vaccination programs used within the US 
broiler industry stems mostly from fears of reduced performance which cause increased 
costs of production.  Upon analysis of these two dietary regimens including the cost of 
the anticoccidial control measure, no differences were observed in the present 
experiment with respect to the cost of production per kilogram of live broiler weight 
when using either salinomycin or Coccivac®-B (Table 4-5).  The increased protein level 
in diet B increased the cost of production compared to the lower dietary protein level 
included in the diet A regimen.  The results of this experiment suggest that substitution  
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Table 4-5. Production cost including dietary and anticoccidial control cost per kilogram 
of live weight of broilers fed two diets varying in protein level with two control methods 
for coccidiosis. 
Cost  
(Cents/kg of live broiler weight) 
Treatment    Diet      
           A                 B          Mean  
Salinomycin  29.31 ± 0.09  30.12 ± 0.14  29.72 ± 0.12  
Coccivac®-B  29.35 ± 0.11  30.00 ± 0.11  29.67 ± 0.11  
Mean   29.33 ± 0.07b  30.06 ± 0.09b      
a,b Means with different superscripts differ at P< 0.05. 
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of ionophoric chemotherapy for a vaccination program with a live oocyst coccidiosis 
vaccine does not reduce performance or increase production cost in broilers reared under 
simulated industry conditions in the presence of field strain Eimeria. 
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CHAPTER V 
CONCLUSIONS 
 Live oocyst vaccination is currently the only available alternative to the use of 
anticoccidial drugs for the control of coccidiosis in the poultry industry.  Its 
effectiveness when judged by final growth characteristics in comparison to medication 
has been heavily debated within the literature.  The objective of this research was the 
evaluation of vaccination and the generation of immunity against subsequent field strain 
Eimeria challenge with a focus on dietary protein level affects on growth parameters of 
broilers.  Vaccination significantly protected broilers against a mixed species challenge 
of E. acervulina, E. maxima, and E. tenella.  Protection was evidenced by reduced lesion 
development six d post challenge, increased body weight gain, and reduced feed 
conversion ratios in vaccinated broilers during the challenge period when compared to 
non-vaccinated broilers reared under similar grow-out conditions.  Decreased body 
weight gain in vaccinated broilers when compared to non-vaccinated broilers in low 
protein diets was observed, but increasing the protein level in the diet of vaccinated 
broilers eliminated this growth depression.  The growth depression in vaccinated broilers 
appeared between d 13 and d 17 after placement.  This time period coincides with the 
second cycling of vaccine strain oocysts within the rearing environment.  The threshold 
established for protein inclusion in the starter diet is 22% before severe affects on 
growth characteristics are observed.  A dietary protein level less than 22% in the starter 
diet is associated with decreased growth characteristics in vaccinated broilers as 
compared to non-vaccinated broilers.   
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 During evaluation of a vaccination program in comparison to chemoprophylactic 
therapy using a common ionophore, salinomycin, during a complete grow-out of 
broilers, live oocyst vaccination yielded growth parameters equivalent to those of 
medicated broilers.  Increasing dietary protein level to 22% allowed for significantly 
higher body weights at the conclusion of the starter period in vaccinated broilers 
compared to vaccinated broilers fed 21.5% dietary protein.  However, this difference did 
not persist throughout the remainder of grow-out.  The comprehensive results of these 
experiments indicate that live oocyst vaccination is a viable alternative to the use of 
medication for the control of coccidiosis during simulated commercial grow-out 
conditions.   Since we did not observe alterations in growth characteristics or an increase 
the cost of production associated with vaccination, we feel coccidiosis vaccination 
should receive greater consideration for use in the US broiler industry. Importantly, 
when preparing to implement a vaccination program for the control of coccidiosis in 
commercial broiler production systems, dietary protein level during the starter phase 
must be closely monitored to ensure good performance. 
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